{
    "msg": "获取章节试题成功",
    "data": {
        "test": {
            "ReturnMessage": "取数据成功",
            "APPEName": "ZY_LCZY_YTMJ",
            "GenDate": "Wed May 15 2019 01:44:51 GMT+0800 (CST)",
            "StyleItems": [
                {
                    "StyleID": 1,
                    "Style": "A1型题",
                    "Explain": "A1型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 31,
                    "TestItems": [
                        {
                            "Title": "3fcabb1c7dedcfc6bb23642038a7448dbde85693bc71a4bc5b3284aae2c8109505eed090e8638024cd88847b3fe978f41da34412bb9b3686c39ce490cb3ccdb6002d5f3f434d7e0d1b1ea72e1796c464306d619e85639a6dc9688b249d3466396150b8897d918968",
                            "Explain": "此题属基本理论题，考核\"氯丙嗪和肾上腺素的作用\"。氯丙嗪的抗精神病作用与阻断脑内中脑-皮层通路和中脑-边缘系统的多巴胺受体相关。此外，还阻断外周血管α受体和M胆碱受体。由于阻断外周α受体，可使血压下降，氯丙嗪过量更易引起低血压。拟肾上腺素药的肾上腺素可激动α受体和β受体，引起皮肤黏膜及内脏血管收缩，增加外周阻力，血压升高的效应可被氯丙嗪阻断，而对血管舒张相关的β受体不受影响，从而使肾上腺素的升压反应翻转为降压反应。选择\"降压反应\"正确答案考生仅占21.8%，而选择\"升压反应\"和\"血压不变\"考生分别占36.1%和22%。其原因是对两药作用没有细致分析比较，单纯考虑肾上腺素是升压药的概念，得出血压升高，或因氯丙嗪可出现降压与肾上腺素升压互相拮抗，得出血压不变等错误答案。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "血压升高"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "血压降低"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "血压不变"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "心率减慢"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "心率不变"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023454,
                            "ATestID": 43023454,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "2a74bb43784dcceaa7468cfa8ede23aa97b76ecdfe6b653735ffb27d39984c4c1fed5869fc4808fa2e21e843d464854cabfe2259a7ec40b8cab691dc4802aa1e56acc1cfdbf4cf97f9523d4d38e62343fd07abc6ce45692b9fb55fcd01204ca49ca0d145ea3f9521",
                            "Explain": "此题是比较治疗慢性心功能不全药物综合优点的试题，涉及强心苷和非强心苷类正性肌力药及减负荷药等。减负荷药包括血管紧张素转换酶抑制剂、利尿药和血管扩张药（硝酸酯类、硝普钠、肼屈嗪、哌唑嗪和酚妥拉明等）。上述众多药物可用于治疗慢性心功能不全，其中血管紧张素转换酶抑制剂卡托普利突出优点是除了发挥一般血管扩张药作用外，还可降低病死率，防止或逆转心肌肥厚、扩张与重构。多数考生选择卡托普利正确答案(61%)，但有12%和10%考生分别选择强心苷和哌唑嗪。而它们虽可治疗慢性心功能不全，但不能防止或逆转心肌肥厚及降低病死率。反映出部分考生忽视卡托普利药物的综合优点。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "强心苷"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "哌唑嗪"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "硝酸甘油"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "酚妥拉明"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "卡托普利"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023457,
                            "ATestID": 43023457,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "46d95df45777d6f44b3ba163d6c40297e59f4de8b0d40200d70617cacecf8449f849d2f57d4908b8",
                            "Explain": "此题是简单应用题，考查考生对治疗脑水肿的首选药物的应用情况。脱水药静注后不易从毛细血管渗入组织，能迅速提高血浆渗透压，使组织间液向血浆转移而产生组织脱水作用，可降低颅内压。甘露醇作为脱水药，是治疗脑水肿、降低颅内压的安全有效的首选药物。螺内酯、氢氯噻嗪、氨苯蝶啶和呋塞米均为一般利尿剂，常用于治疗水肿，但治疗脑水肿的效果较差。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "甘露醇"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "螺内酯"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "氢氯噻嗪"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "氨苯蝶啶"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "呋塞米"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023458,
                            "ATestID": 43023458,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "f557a063b8ab8aeaac14cb421b248bb840bfd9df45612668875adb2c5bbf8e23",
                            "Explain": "此题为记忆和理解相结合的考题。氨苯蝶啶属低效利尿药，作用于远曲小管及集合管阻滞Na[SBjia.gif]通道而减少Na[SBjia.gif]再吸收，因而发挥较弱的利尿作用。同时K[SBjia.gif]的排泄减少，表现为留钾排钠的利尿作用。其利尿作用不受醛固酮水平的影响。选择产生高钾血症正确答案的考生占39%，另有约44%考生选择具有抗醛固酮作用错误答案，显然是错误地把螺内酯（醛固酮拮抗药）作用机制与氨苯蝶啶相混淆。因此，必须在掌握作用机制的基础上，才能掌握氨苯蝶啶的作用特点及不良反应。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "产生低氯碱血症"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "具有抗醛固酮作用"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "产生高血糖反应"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "产生高钾血症"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "产生低钠血症"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023459,
                            "ATestID": 43023459,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "3eba79f5c29b9dd46d8967030bc085f536d5c085695e0f05c957279ad3531cf8cdf5b5c7dd9a0ea7",
                            "Explain": "本试题属基本知识题，考核\"青霉素G的抗菌谱\"。青霉素G主要作用于大多数革兰阳性菌、革兰阴性球菌、螺旋体和放线菌，其中对阳性菌高度敏感，但对分枝杆菌、支原体、衣原体、立克次体、真菌及原虫等无效。从五个备选答案中应选钩端螺旋体为正确答案。选择正确答案的考生占67.7%。少数选择立克次体、支原体、衣原体和真菌，显然是在没有掌握常用的青霉素G的抗菌谱的情况下，随意选择答案。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "立克次体"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "钩端螺旋体"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "衣原体"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "支原体"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "真菌"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023462,
                            "ATestID": 43023462,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "27e110371de3293bfc964eacbf508fa7b66ce54a03d9ab07e9b03b1e2640dfc488d8847689146f770d47dded28b0ad29d88e5d4266d6905e0e3e4b760913b38e053dbca2afd76a3f",
                            "Explain": "此题属理解和记忆相结合的基本知识试题，涉及微生物学细菌结构和生物化学蛋白质生物合成等基础知识。抗菌药物主要干扰病原微生物生化代谢过程，从而影响其结构和功能。一般作用方式有：①抑制细胞壁合成。细菌细胞膜外有一层坚韧的细胞壁，具有保护和维持菌体正常形态和功能的作用。青霉素、头孢菌素影响胞壁结构成分黏肽合成。②抑制蛋白质合成。蛋白质合成主要场所为核糖体，各种抗生素抑制蛋白质合成作用点不同，链霉素、红霉素、四环素等都抑制蛋白质合成。③影响细菌胞质膜通透性。胞质膜位于细菌胞壁内侧，为半透膜。④抑制核酸合成。⑤抑制叶酸代谢。选择正确作用部位是核糖体答案的考生占34.8%，错误选择A和B的考生分别占20%和31%，显然没有掌握链霉素和红霉素的作用部位，蛋白质合成场所及细菌的基本构造，导致选择一系列的错误答案。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "细胞壁上肽聚糖"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "细胞壁上脂多糖"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "细胞质中核糖体"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "细胞膜上中介体"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "细胞染色体DNA"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023464,
                            "ATestID": 43023464,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "38362b11f475a194e2e597e2583eb10b8c2d8b2223735852aded83431586e74e",
                            "Explain": "此题是理解记忆题，考查考生对阿托品不良反应的记忆和理解。阿托品不良反应与其药理作用有密切关系，从5个选项看来，B、C、D和E分别有一点不是阿托品的药理作用，如B选项中的\"肠蠕动增加\"、C选项中的\"调节痉挛\"、D选项中的\"唾液分泌增加\"和E选项中的\"中枢抑制\"等，只有A选项是对的。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "瞳孔轻度扩大、皮肤潮红"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "肠蠕动增加、烦躁不安"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "调节痉挛、心率加快"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "肠蠕动减速少、唾液分泌增加"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "中枢抑制、心率减慢"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023468,
                            "ATestID": 43023468,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "5541ccbf8c7f0322bf304f280495d4578a83935842ec2665904344b1f728fb83a99c4daaf6e4ea6e",
                            "Explain": "此题是记忆题，考查考生对β受体阻断药作用的记忆。β受体阻断药的药理作用是考生必须要记忆的内容。如果能了解β受体激动后的效应，则基本上可以排除A～D的各选项，而只有E选项是正确的。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "加快心率"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "松弛支气管平滑肌"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "促进脂肪分解"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "增加肾素分泌"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "降低心肌收缩力"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023469,
                            "ATestID": 43023469,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "e3299faf859cac847a5f7313c09369a509cb7c178d6183a85a496d52358a0475ba59ab4d7f6cc6c902ed89643a728cb3",
                            "Explain": "此题是简单应用题，考查考生对普鲁卡因作用特点和临床应用的了解。普鲁卡因是临床常用的局部麻醉药，其作用特点为脂溶性低，故对黏膜穿透力弱，本考题要求考生了解局部麻醉药的脂溶性常与黏膜穿透力有相关性的问题，此特点常与药物的临床应用密切相关。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "脂溶性低"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "对黏膜穿透力强"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "主要用于浸润麻醉"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "避免与磺胺药合用"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "可引起过敏反应"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023470,
                            "ATestID": 43023470,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "cbf38f524a6c8dbf9552d57217a78b7a4265a88a753b15e792a762bc6326f6bc",
                            "Explain": "此题是简单应用题，考查考生对地西泮临床应用的了解。地西泮作用特点为主要延长NREMS的第2期，明显缩短SWS期。因此，药物安全范围较大，由于对REMS的影响较小，故其依赖性和戒断症状较轻。地西泮是目前临床上广泛使用的镇静催眠药。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "癫痫大发作"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抑郁症"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "精神病"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "慢性疼痛"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "催眠"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023471,
                            "ATestID": 43023471,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c579bbb4f89c699ad595989033459287b0c71408fef71b0c1c5ebebcaee824a70495ad60fc0113b8889ce3736f634eba",
                            "Explain": "此题是记忆题，考查考生对苯妥英钠不良反应的记忆。抗癫痫药物是临床上使用疗程较长的药物之一，其致畸胎作用具有重要的临床意义，但由于该题涉及药物较多，且药物产生的不良反应与其药理作用之间没有明确的相关性，因此要准确回答问题有一定的难度。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "苯妥英钠"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "苯巴比妥"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "卡马西平"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "苯二氮[WZcaozhuo.gif]类"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "乙琥胺"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023472,
                            "ATestID": 43023472,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "be41b82d51dc4f9bfd11034f9691dc7368f92481c3f254715296a491d7fc379e5abd88c356c81944",
                            "Explain": "此题是解释题，考查考生对左旋多巴体内过程的记忆和理解。左旋多巴体内过程特点具有重要临床意义。该药由于易在外周脱羧成为多巴胺而失去其治疗作用，因为外周的多巴胺不能进入脑内发挥治疗帕金森病的作用。此外，左旋多巴口服后的吸收率和胃排空时间与胃内pH有关，胃内酸度增加可降低其生物利用度。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "外周用药大部分可进入中枢"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "口服后胃排空时间与胃内pH有关"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "口服后小肠吸收缓慢"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "外周多巴脱羧酶抑制剂不减少其用量"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "血药浓度个体差异较小"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023473,
                            "ATestID": 43023473,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c3c80604e6441280b3f41e1e54c93ceddb7ec3080cc52fc75d787dda01cf0807",
                            "Explain": "此题是理解应用题，考查考生对阿司匹林作用的记忆并加以运用。阿司匹林药理作用较为广泛，该题主要考点为药物对凝血功能的影响。血小板聚集是血栓形成的重要环节，TXA[XB2.gif]可诱导血小板聚集，COX-1可促进TXA[XB2.gif]生物合成；而阿司匹林能与COX-1氨基酸序列第530位丝氨酸共价结合，通过乙酰化不可逆抑制了COX-1的活性，从而使TXA[XB2.gif]生物合成减少，血小板聚集作用明显减弱而发挥抗凝血作用。利用阿司匹林这一重要作用，临床上广泛用于预防血栓形成。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "使血小板内TXA[XB2.gif]合成减少"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "激活COX-1活性"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "促进PGs合成酶的活性"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "促进血小板聚集"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "促进凝血酶原形成"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023474,
                            "ATestID": 43023474,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "bc4670780d1ad94704e5d739efb961a8ee6e7066c30d203b13e6b1e8755c0f9b23fd39297e7f6c01afebd6d4b0f52d07efce60233999ebc5",
                            "Explain": "此题是记忆题，考查考生对钙拮抗药作用的记忆。钙拮抗药具有多方面药理作用，包括负性肌力、负性频率、负性传导及抑制细胞外Ca[SB2jia.gif]内流作用。记忆了这些基本作用后，就很容易知道E选项是错误的，因为不可能是加快房室结传导，而是减慢房室结传导。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "减少心肌细胞内Ca[SB2jia.gif]"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抑制血小板聚集"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "增加冠状动脉血流量"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "增强红细胞变形能力"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "加快房室结传导"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023475,
                            "ATestID": 43023475,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "fee54a486fa44768d243cd2086cd3da792ee826a83daceee903438caa4618b3e9982e0c955f901fb58cdda8c62209cb06410aee9bbd48bcc",
                            "Explain": "此题是解释题，考查考生对胺碘酮主要作用的记忆和对心肌电生理特性的理解。胺碘酮主要作用是延长心肌动作电位时程，其影响的主要环节是胺碘酮明显延长心房肌、心室肌、房室结和浦肯野纤维的APD和ERP，此作用与其阻滞K[SBjia.gif]通道有关。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "Na[SBjia.gif]外流减少"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "Ca[SB2jia.gif]外流减少"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "K[SBjia.gif]外流减少"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "Mg[SB2jia.gif]外流减少"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "Cu[SB2jia.gif]外流减少"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023476,
                            "ATestID": 43023476,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "2fccf26437368160f8accee643bd3d2469618fd323741946483637485f0109d0",
                            "Explain": "此题是记忆题，考查考生对硝酸甘油作用的记忆。此题主要考点是记忆硝酸甘油的药理作用，在5个选项中，除D外，其他均不是硝酸甘油的药理作用，因此，只有D选项是正确的。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "升高血压"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "减慢心率"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "心肌收缩力降低"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "开放侧支血管"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制NO释放"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023477,
                            "ATestID": 43023477,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c8ad0cd9e5f79743218400551894ed7eeb4e41caba37607334d8442e58a3b5581928186234833adb",
                            "Explain": "此题是解释题，考查考生对糖皮质激素的不良反应的理解。糖皮质激素的不良反应包括诸多方面，大致包括类肾上腺皮质功能亢进综合征、诱发或加重感染、心血管系统并发症、消化系统并发症、肌萎缩、骨质疏松、伤口愈合延缓和青光眼等。选项B中的\"血糖下降\"是不对的，实际上其不良反应是血糖升高。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "向心性肥胖、高血压"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "加重感染、血糖下降"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "骨质疏松、青光眼"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "消化道溃疡、肌萎缩"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "伤口愈合延缓、高血脂"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023478,
                            "ATestID": 43023478,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "987856238719b1243acce8906bbb42858f9062910cfce055157b3675cd05da138a2ef451820e638f5c65db128a9a4582",
                            "Explain": "此题是记忆题，考查考生对氨基糖苷类抗生素不良反应的了解。氨基糖苷类抗生素的不良反应有多方面，其中耳毒性是重要不良反应之一，对这一反应临床医生都会给予密切的关注。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "再生障碍性贫血"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "耳蜗听神经损伤"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "肝毒性"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "心脏毒性"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "消化道反应"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023480,
                            "ATestID": 43023480,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "1dceeb51c5375c6cafe217669769f851b0f6ac8ece5454680808f1ef6ce537a3c69b8e90d63a6b96b8af03c71950661bdb8d27645e47669f60a9988e53333d37",
                            "Explain": "本题属于基本知识试题，考核“血管紧张素转换酶抑制剂降压特点”。血管紧张素转换酶抑制剂通过抑制血管紧张素Ⅱ和醛固酮的生成，使其含量减少，以达到血管扩张、血容量减少，血压下降的目的。还可减少缓激肽的降解，使血中缓激肽浓度增加，缓激肽可扩张血管使血压下降。血管紧张素转换酶抑制剂降压作用较强，对收缩压和舒张压均有降压作用，适用于各型高血压，长期服用无耐受性。降压时不伴心率加快，还可扩张肾血管，增加肾血流量。长期应用不易引起电解质紊乱和脂质代谢障碍，增强机体对胰岛素敏感性。此外，还能预防和逆转心室肥厚、血管的重构，发挥直接或间接保护作用，降低高血压死亡率，因此是常用的抗高血压药。选择正确答案的考生占41.7%，说明相当多考生对常用的血管紧张素转换酶抑制剂作用和应用特点和优点等基本知识没有掌握，导致错误选择。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "可用于各型高血压，有反射性心率加快"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "对肾脏无保护作用"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "可防治高血压患者心肌细胞肥大"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "长期用药易引起电解质紊乱"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "对高血压患者的血管壁增厚无防治作用"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028435,
                            "ATestID": 43028435,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "ac4c4992222e1b19b178be1f6224e590fbf3766108c5f7ca9e0f97d223430433737ef914003536b313cdd414d639f246",
                            "Explain": "此题属抗生素的基本知识试题，考核“抗菌药的作用机制”。常用抗菌药物作用机制主要如下：①抑制细菌细胞壁的合成，如青霉素、头孢菌素等；②影响细菌胞质膜通透性，如多黏菌素、制霉菌素和两性霉素等；③抑制蛋白质合成，蛋白质合成的主要场所为核糖体，多种抗生素对核糖体作用点不同，如大环内酯类、氨基糖苷类、四环素类、林可霉素类和氯霉素；④抑制叶酸代谢：磺胺类与甲氧苄啶分别抑制二氢叶酸合成酶和二氢叶酸还原酶，妨碍叶酸代谢，最终影响叶酸合成；⑤抑制核酸代谢，如喹诺酮类通过抑制DNA回旋酶而抑制DNA合成，利福平抑制DNA依赖的RNA多聚酶等。选择喹诺酮类正确答案的考生仅占27.4%，多数考生选择其他类型作用方式，其原因是对蛋白质、核酸、叶酸等合成的概念不清，另外对常用抗菌药作用方式概念模糊等，导致随意选择。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抑制70S始动复合物的形成，抑制蛋白质合成"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抑制DNA回旋酶，阻碍DNA合成"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "竞争二氢叶酸合成酶，使敏感菌的二氢叶酸合成受阻"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "抑制二氢叶酸还原酶，影响核酸合成"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制细菌细胞壁黏肽合成酶，阻碍细胞壁黏肽合成"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028436,
                            "ATestID": 43028436,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "a1f46dc1ce93ce94ae43f6ebe001e5e089b9b3a5a32a713297d9c98b036879cf478921642a3d3a8c",
                            "Explain": "此题属于基本理论试题，考核“解热镇痛药的作用机制”。本题涉及体温的生理性调节和前列腺素（PG）广泛的生物学作用。解热镇痛药的机制和PG紧密相关，主要抑制PG合成酶（环加氧酶），减少PG的合成。重要区别在于解热的机制是抑制中枢（下丘脑）PG合成，镇痛的机制是主要抑制外周炎症局部PG合成。多种PG都有产热增加，散热减少的致热作用，PG除本身致痛外，尚能提高感觉神经对缓激肽等致痛物质的敏感性。有的考生选择抑制外周PG合成，反映此部分考生忽视解热和镇痛的作用机制的部位。部分考生选择相反的增加PG显然更是错误的答案。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抑制中枢PG合成"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抑制外周PG合成"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "抑制中枢PG降解"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "抑制外周PG降解"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "增加中枢PG释放"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028437,
                            "ATestID": 43028437,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "fa738c380d59dc60d3129b95b48da61632dd7e1082a7d7dbee36d3c3315c47fc1b51e65d7cd42bc4f457c0a0e08c6c3b",
                            "Explain": "此题是药代动力学的基本概念题，主要涉及药物的吸收、分布、代谢和排泄四个环节。吸收速度主要影响作用出现快慢，吸收的程度主要影响药物作用的强弱。分布过程与药物在血浆或靶组织中的浓度有关，药物与血浆蛋白结合率的大小是影响体内分布的重要因素，药物的体内分布不仅影响药物储存和消除速率，也影响药效与毒性，分布过程使血药浓度降低，也是药物自血浆消除的方式之一。药物转化指在体内发生化学结构改变，大多数经转化后药理活性减弱或消失，且有利于排泄。排泄指药物及其代谢物排出体外过程。药物自体内消除包括代谢转化与排泄两个过程。消除的快慢对制订和调整给药方案（用药剂量和给药间隔时间）具有重要意义，用药的间隔时间主要取决于消除速度，选择此正确答案者占60%，错误选择排泄速度和血浆蛋白结合率者分别占20.6%和11.5%。显然，部分考生对药代动力学四个过程基本概念不清楚。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "药物与血浆蛋白的结合率"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "药物的吸收速度"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "药物的排泄速度"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "药物的消除速度"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "药物的分布速度"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028438,
                            "ATestID": 43028438,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "f2de5a10aa3d3fcd8f373c47786dfdbc51883d054eaaff06b165f6ea544c4d8ec7f8cf4ea4ae29e3f6541466665354e68a9cbcadd1057442030968b89af649fd",
                            "Explain": "本题属“抗癫痫药”基本知识试题，考核“具有抗癫痫作用而无镇静催眠作用的药物”。备选答案中的地西泮和苯巴比妥及氯硝西泮都具有镇静、催眠和抗癫痫作用。扑米酮在体内转化为苯巴比妥和苯乙基丙二酰胺都具有抗癫痫作用，前者还具有镇静、催眠作用。苯妥英钠具有抗癫痫作用而无镇静催眠作用。选择苯妥英钠正确答案考生仅占40.8%。其他考生分别选择地西泮、苯巴比妥、扑米酮等错误答案，主要原因是没有掌握常用各抗癫痫药的作用及对扑米酮的体内代谢认识模糊，导致错误选择。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "地西泮"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "苯妥英钠"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "苯巴比妥"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "扑米酮"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "氯硝西泮"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028440,
                            "ATestID": 43028440,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "55dc07c48b2f9c226e6ef669cc9fcb5ae732de5155c84e30fbf5436639e45c381c28e5fa1629fd0ecddc212ffabce3b8",
                            "Explain": "此题是以理解为主的考题，强心苷治疗心房颤动机制与心脏的生理、颤动的病理密切相关。心房颤动主要危险在于心房过多的冲动传到心室引起心室率过快，妨碍心室泵血功能，导致严重循环障碍。强心苷主要作用是减慢房室传导，阻止过多颤动冲动传入心室，从而减慢心室率，改善心搏血功能。但对多数患者并不能消除心房颤动。本题只有36.5%考生选择此正确答案。另有33.6%和12.5%考生分别选择延长心房不应期和缩短心房有效不应期。反映出部分考生对颤动病理、强心苷药理等基础知识概念模糊，不能选择正确答案。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "缩短心房有效不应期"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "减慢房室传导"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "抑制窦房结"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "直接抑制心房颤动"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "延长心房不应期"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028441,
                            "ATestID": 43028441,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "56de0885f4e6be2df1b4c506499fa986f3b2eccb1312fcb7dd2b66507f610307cac778a377ffb963bc24f9e01d2031c2427679cd27c884ba1a324aec3d95156f",
                            "Explain": "此题属基本知识试题，奥关拉唑主要用于治疗消化性溃疡。消化性溃疡的发病与黏膜局部损伤和保护机制之间平衡失调相关。损伤因素（胃酸、胃蛋白酶）的增强、保护因素（黏液、HCO[SBjianXB3.gif]屏障和黏膜修复）的减弱或幽门螺杆菌的侵蚀，均可引起消化性溃疡，所以临床常用的治疗药有抗酸药、胃酸分泌抑制药、胃黏膜保护药及抗幽门螺杆菌药。五个备选答案中有四个属于胃酸分泌抑制药（胃壁细胞质子泵抑制药，胃泌素受体阻断药，H[XB2.gif]受体阻断药和M胆碱受体阻断药），多数考生选择胃壁细胞质子泵抑制药正确答案（占67%），少数考生选择H[XB2.gif]受体阻断药（占13%）和其他错误答案，显然是没有掌握作用机制，甚至与其他治疗消化性溃疡药相混淆。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "黏膜保护药"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "胃壁细胞质子泵抑制药"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "胃泌素受体阻断药"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "H[XB2.gif]受体阻断药"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "M胆碱受体阻断药"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028445,
                            "ATestID": 43028445,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c579bbb4f89c699a947fe618867d968592c1b6c908f9b672f1bc7523f4a19d8ff075b8fd622678410e5730285c37f9a57df0d78ae74be96bb681233f6d4aae4f",
                            "Explain": "此题属于糖皮质激素基本知识试题，考核“抗炎作用”，也涉及其他基础学科。糖皮质激素具有强大的非特异性抗炎作用，能对抗各种原因引起的炎症。在炎症早期，可减轻渗出、水肿、毛细血管扩张、白细胞浸润和吞噬反应，可减轻红、肿、热、痛等炎症反应症状；在炎症后期，可抑制毛细血管和成纤维细胞增生，延缓肉芽组织生成，防止粘连及瘢痕形成，减轻后遗症。糖皮质激素在抑制炎症、减轻症状的同时，也降低机体防御功能，可致感染扩散，阻碍创口愈合。其他有免疫抑制作用、抗毒作用及抗休克作用等。但本题只有50%考生选择能对抗各种原因引起的炎症的正确答案，另有31%和10%考生选择提高机体防御功能和抑制病原体生长的错误答案，反映出部分考生对糖皮质激素的基本知识模糊。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "对抗各种原因如物理、生物等引起的炎症"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "能提高机体的防御功能"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "促进创口愈合"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "抑制病原体生长"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "直接杀灭病原体"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028446,
                            "ATestID": 43028446,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "efd054ec5626010979e5559628bbff86946ac6da1988982e162fcb176ddb6b6a155057ad4d25f801e73fd1f06f9d4965f475f8b2005ae65c2bbc3c80c3fd7fa5",
                            "Explain": "本试题属基本知识试题，考核“氟喹诺酮类药理学共同特性”。氟喹诺酮类的共同特性是：①抗菌谱广；②细菌对本类药与其他抗菌药间无交叉耐药性；③口服吸收良好，体内分布广；④不良反应少，大多较轻微；⑤应用较广。备选答案中的“不良反应较多”，显然是错误的。选择正确答案考生仅占49.7%，这说明半数考生没有掌握重要的氟喹诺酮类药的共性，将影响到氟喹诺酮类药物的合理应用。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抗菌谱广"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "口服吸收好"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "与其他抗菌药物无交叉耐药性"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "不良反应较多"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "体内分布较广"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028448,
                            "ATestID": 43028448,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "9c94f5f866c420b9b9159895a4e1606a1e7b558ecf8f30488ef1d500e7400d898885efc6ec1c6f59ca495157120f6319",
                            "Explain": "此题是理解判断题，考查考生对药物副作用的理解。首先必须明确药物副作用的定义。副作用是药物在治疗剂量下所产生的，与治疗目的无关的药物反应，这种反应一般并不严重，由于药物副作用常可随着治疗目的改变而变化，因此副作用常难以避免，其产生原因是由于药物作用的选择性低所致。如阿托品用于治疗由于胃肠平滑肌痉挛所致腹疼时，治疗作用是其发挥了胃肠平滑肌解痉作用，而此时阿托品所具有的另一作用，即其抑制腺体分泌作用所致的口干就成为药物的副作用；相反，当阿托品在麻醉前使用时，其抑制呼吸道腺体和唾液腺分泌作用便成为药物的治疗作用，而其平滑肌解痉作用所致的便秘、腹胀等反应就变成了药物的副作用。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "为治疗剂量时所产生的药物反应"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "为与治疗目的有关的药物反应"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "为不太严重的药物反应"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "为药物作用选择性低时所产生的反应"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "为一种难以避免的药物反应"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028450,
                            "ATestID": 43028450,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "9b9432a4cee3c55b441f3c534f6ebeb3b5d2bbff75f3ee88dc44e29a522c9265da28258527ca1421",
                            "Explain": "此题是记忆结合理解的分析题，考查考生对毛果芸香碱基本作用的记忆和理解。毛果芸香碱对眼睛的作用是该药物的基本药理作用，主要包括缩瞳、调节痉挛和降低眼内压。因此如果知道了毛果芸香碱的缩瞳作用就可排除B和D的选项，知道其第二项作用后就可排除A选项，而知道其第三项作用后就可排除E选项，最后选择C。当然毛果芸香碱的三大作用之间存在着相互依赖关系，如由于毛果芸香碱的缩瞳作用导致了其降低眼内压的作用，这就要求考生理解毛果芸香碱的作用而不是单纯记忆。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "缩瞳、调节麻痹、降低眼内压"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "扩瞳、调节麻痹、升高眼内压"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "缩瞳、调节痉挛、降低眼内压"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "扩瞳、调节痉挛、降低眼内压"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "缩瞳、调节痉挛、升高眼内压"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028451,
                            "ATestID": 43028451,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "2a1dac2be92b225b57298e516bb322aa915d83bb02e0de7e1e1c0cb8e7ad0f83b289a95d600d253c",
                            "Explain": "此题是结合临床的理解分析题，考查考生对M、N激动效应的分析和理解。有机磷酸酯类急性中毒机制为水解乙酰胆碱的胆碱酯酶活性被不可逆抑制，从而呈现体内乙酰胆碱堆积过多，引起中毒。主要表现为M、N胆碱受体过度兴奋的效应。因此要回答此题的关键是必须了解M、N胆碱受体过度兴奋效应的具体表现。其中A、B、C和E均有部分或全部内容不对，只有D是对的，而D选项要求考生分析乙酰胆碱对神经节N受体的效应，由于交感神经节N受体和副交感神经节N受体激动后其节后神经末梢释放递质不同，因而对心血管作用不同。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "腺体分泌减少、胃肠平滑肌兴奋"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "膀胱逼尿肌松弛、呼吸肌麻痹"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "支气管平滑肌松弛、唾液腺分泌增加"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "神经节兴奋、心血管作用复杂"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "脑内乙酰胆碱水平下降、瞳孔扩大"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028452,
                            "ATestID": 43028452,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "3eba79f5c29b9dd416e16c7400aa8aaef3bd284c36d37b37e987088d52104e844b31f614cf3f128f",
                            "Explain": "此题是简单应用题，考查考生对青霉素G应用的了解。此题的考点是要求考生熟悉青霉素G的抗菌谱，其中铜绿假单胞菌不是青霉素G的敏感菌，此茵对妥布霉素、庆大霉素和头孢匹罗较敏感。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "革兰阳性球菌"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "革兰阳性杆菌"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "革兰阴性球菌"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "铜绿假单胞菌"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "梅毒螺旋体"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028464,
                            "ATestID": 43028464,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 5,
                    "Style": "A1/A2型题",
                    "Explain": "A1/A2型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 69,
                    "TestItems": [
                        {
                            "Title": "0bf0db2ec76acb6cf38674a3ceb5d08e282f019fec1089feb715cd454cb16f8c1722ecee81a3305a3c5e4bc51b5bbdd3",
                            "Explain": "①常见错误是选A。硝酸甘油的基本作用是松弛平滑肌，尤其血管平滑肌松弛明显。其作用机制是硝酸甘油在平滑肌细胞及血管内皮细胞中被生物降解，产生NO，通过拟内源性血管内皮舒张因子(EDRF)，即一氧化氮而起作用；②硝酸甘油能改善心内膜供血，这是由于心内膜下血管是由心外膜血管垂直穿过心肌延伸而来的，因此心内膜下血管易受心室壁肌张力及室内压力影响。张力与压力增高时，内膜层血流量减少。在心绞痛急性发作时，左心室舒张末期压力增高，所以心内膜下区域缺血最为严重。硝酸甘油降低左心室舒张末期压，舒张心外膜血管及侧支血管，使血液易从心外膜向心内膜下缺血区流动，增加心内膜供血，故E的论述是错误的，为本题应选答案。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "通过EDRF使血管平滑肌松弛"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "降低左室舒张末期压力"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "舒张冠脉侧支血管"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "降低心肌耗氧量"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "改善心内膜供血作用差"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007149,
                            "ATestID": 43007149,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0adbdae2123de31eb733c4a07addf8d09268aae94d151e4e09e5a973c3a1ef267ca8de469e7ba419c32fee3c488d3347",
                            "Explain": "青霉素是目前治疗多数革兰阳性球菌感染如肺炎球菌肺炎，革兰阴性球菌感染如淋球菌感染的淋病及脑膜炎球菌、梅毒螺旋体等感染的首选药，用于治疗溶血性链球菌引起的扁桃体炎、猩红热等及草绿色链球菌引起的心内膜炎，还可治疗放线菌病、钩端螺旋体病、回归热等。青霉素是预防感染性心内膜炎发生的首选药。链霉素和庆大霉素属于氨基糖苷类抗生素，对革兰阴性杆菌作用较强，主要用于G-杆菌所致的全身感染，如脑膜炎、呼吸道、泌尿道、皮肤软组织、胃肠道等。磺胺类药物和四环素均为广谱抑菌药，磺胺类由于其不良反应应用受限，常用于流脑及鼠疫的治疗，四环素细菌感染不作为首选，主要用于立克次体、衣原体、支原体及螺旋体感染。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "磺胺类药物"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "链霉素"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "青霉素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "庆大霉素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "四环素"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007150,
                            "ATestID": 43007150,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "02b50e5b583d09034e5cd2f701973522144d94b9c0d0f09f5ebeecb9236f392e32dfcbfadbd519ae392f286d0c5fb9d472c784c61dda5a0a917f03625a116fd59b7444c317374d1b1e902e9d97c2f574c3047a464ffb0441e53d0cdb54bafb2579d6bb65561c11c70640726310a40a09222477567e56cce6e6477ad923b4808a",
                            "Explain": "双氢克尿噻（氢氯噻嗪）为中效能利尿药，为抗高血压的一线药物，尤其适用于伴有水肿的高血压患者，轻症高血压可单独用药，中重度与其他抗高血压药联合应用。本题患者伴有水肿，因此可选用双氢克尿噻。而美托洛尔收缩支气管，卡托普利导致干咳，此病人有气促症状，最好不用美托洛尔和卡托普利。硝苯地平具有很强的舒张血管作用，可导致血压急剧下降，放射性的兴奋交感神经，引起心率加快，而病人本身心率过快，因此也不能选用。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "美托洛尔"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "卡托普利"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "双氢克尿噻"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "哌唑嗪"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007151,
                            "ATestID": 43007151,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "2071f207fb99614d938c32908db70304a94f7cab921bf3bd9cbd9e931b488adf4e5cf33068a8af6304c31294fba5be91715f2eb63c5421bf",
                            "Explain": "肾上腺素对血管作用取决于各器官血管平滑肌上α和β受体的分布密度以及给药剂量的大小。皮肤、肾和胃肠道等器官的血管平滑肌α受体占优势，表现黏膜强烈收缩（A选项），内脏血管尤其是肾血管收缩显著。对脑和肺血管收缩作用十分微弱，有时由于血压升高而被动扩张（B选项）。肝脏和骨骼肌血管以β受体占优势，因此表现为舒张作用（D选项）。而冠状动脉的舒张主要受心脏代谢产生的影响，肾上腺素可兴奋心脏，增加心肌耗氧量，使代谢产物增多，促进冠脉扩张（E选项）。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "皮肤、黏膜血管收缩强"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "微弱收缩脑和肺血管"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "肾血管扩张"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "骨骼肌血管扩张"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "舒张冠状血管"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007152,
                            "ATestID": 43007152,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8bc821a9002ee90efeecaa4cda142ba06f629ebd26d4311f",
                            "Explain": "①偶有错选D者。氯丙嗪可以用于顽固性呃逆，作用机制目前尚不清楚，但有人认为氯丙嗪有强大的止吐作用，是作用于化学感受器触发带(CTZ)和呕吐中枢，对CTZ和呕吐中枢的D[XB2.gif]受体阻断而发生。呃逆中枢位于呕吐中枢的附近，故对呃逆中枢也有抑制作用；②本组答案除C外均为氯丙嗪的适应证，氯丙嗪有强大的止吐作用，但对晕动症时的呕吐是无效的，这可能是它不影响前庭神经功能。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "精神分裂症"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "人工冬眠法"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "晕动症时的呕吐"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "顽固性呃逆"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "躁狂症及其他精神病伴有妄想症言"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007153,
                            "ATestID": 43007153,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "04bcde7efa75f589deca41065c18409d0bce30f0d1c648addd30271134f77ba03057c84f2a7ab22c",
                            "Explain": "①错选B。吗啡类镇痛药的作用部位的确是中枢神经系统，但这太笼统。目前对此类药的作用机制已很明确，是模拟内源性的阿片肽，激动阿片受体而产生。中枢的阿片受体分布广泛，密度不均。在脊髓胶质区，丘脑外侧、脑室导水管周围密度高，这些结构与痛觉整合及感受有关，故是镇痛的主要部位；②错选D。这与吗啡的缩瞳有关；③错选C。这些部位与吗啡引起的情绪反应及欣快感有关。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "脊髓胶质区、丘脑内侧、脑室及导水管周围灰质"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "中枢神经系统"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "边缘系统与蓝斑核"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "中脑盖前核"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "大脑皮层"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007154,
                            "ATestID": 43007154,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "efd054ec5626010916597a5c731688f05c801203ada8f3c16fb549c9fedaa5126cbfed7bc3f6358acde21766795b76e060a0f3e21392d4746248ac58a295300c997769045b5d70a7",
                            "Explain": "血管紧张素转化酶抑制剂(ACEI)如卡托普利能抑制ACE，减少循环组织中的血管紧张素Ⅱ(ATⅡ)，使血管扩张，血压下降。可用于各型高血压。而且降压时不引起反射性心率加快。可逆转心肌肥厚，有效地治疗慢性心力衰竭，对肾脏有保护作用，长期用不引起电解质的紊乱。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "引起反射性心率加快"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "可用于各型高血压"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "对肾脏有保护作用"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "可防治高血压患者心肌细胞肥大"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "减少循环组织中的血管紧张素Ⅱ"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007155,
                            "ATestID": 43007155,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "002235026aa4a92284daa92600ef466bc0fc8ab2fe7b44f49f692904afdf42e7fb29921d65e69a7ff455585d0e14b208075c173d1b7cdec6",
                            "Explain": "糖皮质激素类具有抗炎作用，主要用于中毒性感染或同时伴有休克者，如中毒性菌痢、重症伤寒、爆发型流行性脑膜炎及败血症，可增加机体对有害刺激的耐受性，减轻中毒反应。但由于糖皮质激素没有抗菌作用，同时降低机体防御力，单用激素有可能导致感染扩散而加剧感染，因此在治疗严重感染时，必须在有效、足量的抗菌药的应用基础上应用激素。而目前临床缺乏有效的抗病毒药物，因此，病毒感染一般不用激素。腮腺炎为病毒感染，不宜应用糖皮质激素。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "中毒性痢疾"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "中毒性肺炎"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "败血症"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "腮腺炎"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "重症伤寒"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007156,
                            "ATestID": 43007156,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "d87d5420d1dccb438761f23a925aab81b758431db450dc79dc82f334d3604e22c81b4b107ce225e9ce044fef7769b19b9587c0a0486d396a",
                            "Explain": "①常见错选A，发生率约25%。直立性低血压是氯丙嗪的不良反应，常发生于注射用药之后，是α受体阻断的结果，但并非题意，本题问的是“长期应用”，而直立性低血压一次用量过大即可发生；②最常见的不良反应应该是锥体外系反应，这是因为氯丙嗪抗精神失常是阻断中脑皮质、中脑-边缘系统的多巴胺受体，对精神分裂症病人用药需要长时间，这样氯丙嗪也同时阻断了黑质-纹状体的多巴胺受体，会发生锥体外系反应。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "直立性低血压"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "过敏反应"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "锥体外系反应"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "内分泌障碍"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "消化道症状"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007157,
                            "ATestID": 43007157,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "da976582826c5cc4c18b8d1b660fc2358f4dd2229dcdaa98d9e3305376538e2316b77b5692b795f8ffcebf128003572a",
                            "Explain": "强效利尿药中依他尼酸最易发生耳毒性，呋塞米次之，布美他尼的耳毒性最小，为呋噻米的1/6。对听力有缺陷及急性肾衰者，权衡利弊，宜选用布美他尼。本题易错选D或E。这两种药物虽然没有耳毒性，但均为弱效利尿药，不适宜“急性肾衰者”。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "呋塞米"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "依他尼酸"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "布美他尼"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "阿米洛利"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "螺内酯"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007158,
                            "ATestID": 43007158,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8d998bc089b5f832ee5f765fb3747d03fb35b44812982b334ada25d1caa1645dd8ae650e97f62336ad7d92fec6dc575e",
                            "Explain": "常见错选B。大剂量碘剂产生抗甲状腺素作用。抑制甲状腺激素的合成与释放，产生的作用快而强。但是大剂量碘剂达最大效应后若继续用药，反使碘的摄取受抑制，胞内碘离子浓度下降，因此失去抑制激素合成的效应，甲亢的症状可又复发，故大剂量碘剂不能单独用于甲亢内科治疗。而甲巯咪唑抑制甲状腺过氧化物酶，从而抑制了甲状腺激素的合成，发挥治疗甲亢作用。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "小剂量碘剂"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "大剂量碘剂"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "甲状腺素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "甲巯咪唑"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "以上都不是"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007159,
                            "ATestID": 43007159,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "496a02ee60594a06d33f701743d423826f09db9991a174a9c47d37767a45180e63ba556c1fcb75bc87c50aa2aa1e9d8d39e616211e6369eca21a0f55e71d8af8836e065f7b3e8b3a22187033e31bf353a4185ccbb7e7fb3c06d7a9ff2f7074ebd9e58148b5063a3f7f58ff192da3c905",
                            "Explain": "糖尿病患者应用胰岛素的情况为：(1)1型糖尿病；(2)2型糖尿病口服降糖药不能控制血糖；(3)糖尿病并发症：酮症酸中毒和非酮症性高渗性昏迷；(4)糖尿病合并症：主要是各种应激情况如重度感染、消耗性疾病、高热、妊娠、创伤及手术等。本题中患者处于妊娠期，无论何型糖尿病均需应用胰岛素。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "瑞格奈特"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "氯磺丙脲"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "胰岛素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "优降糖（格列本脲）"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "降糖灵（苯乙双胍）"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007160,
                            "ATestID": 43007160,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "a6811575747882e7aea3eca41c4ae33cff3f2785be2bc91e349f74fc5d04eec4a55ee79c383bdca9c754b6f7648b7ec65ca61e02f8965e3f3d5e52a65911cde1",
                            "Explain": "不同类型的降糖药物其降糖的机制不一。阿卡波糖是α葡萄糖苷酶抑制剂，其作用机制主要是通过延缓小肠黏膜对葡萄糖的吸收，因此只有与食物同时服用才能发挥作用。甲苯磺丁脲、氯磺丙脲、格列本脲和格列喹酮均为磺脲类药物，其作用机制主要是通过刺激胰岛B细胞分泌胰岛素从而降低血糖，由于从服药、吸收到发挥药效需要一段时间，因此常要在进餐前半小时左右服用。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "甲苯磺丁脲"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "氯磺丙脲"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "格列本脲"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "阿卡波糖"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "格列喹酮"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007161,
                            "ATestID": 43007161,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "d512bef81fc02595727c5d90c56daea9a18695011b8aeb58e68fb9100376037dbb7a5bb2b5d952c643576436374ab606",
                            "Explain": "卡比多巴不能通过血脑屏障入脑，故需和左旋多巴合用时，以减少左旋多巴在外周组织的脱羧作用，因而可使较多的左旋多巴到达黑质-纹状体而发挥作用，从而提高左旋多巴的疗效。苯扎托品和苯海索为抗胆碱药，可抑制纹状体功能而治疗帕金森病；左旋多巴可补充黑质的多巴胺神经递质，溴隐亭可直接激动多巴胺受体，单独应用均可治疗帕金森病。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "苯扎托品"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "卡比多巴"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "苯海索"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "左旋多巴"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "溴隐亭"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007162,
                            "ATestID": 43007162,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "374746796cb9a5542bfea226c4b860167ef2f64a428c480fa0e2b91e71406b9676ae3037ce32f817cb7b5f8ef14eadc55e9576314a41ecac",
                            "Explain": "①错选A。胺腆酮的化学结构与甲状腺素相似，阻断T[XB3.gif]、T[XB4.gif]与其受体结合，亦是抗心律失常的机制之一；②胺腆酮除了影响离子通道外，还具有非竞争性地阻断α、β受体作用，降低窦房结和普肯耶纤维的自律性与抗β受体有关，扩张冠脉，降低外周阻力与α受体阻断有关。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "拮抗T[XB3.gif]、T[XB4.gif]"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "减慢普肯耶纤维和房室结的传导速度"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "延长心房肌、心室肌、普肯耶纤维的APD、ERP"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "阻滞心肌细胞钠、钙及钾通道"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "对α、β受体无阻断作用"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007164,
                            "ATestID": 43007164,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "d4181b6893bc6f74573b60e6a95fd5c2a5c31713d0f4628bbd66320afd1690c55d77a1292a4094428a425a537baac4eb13b20afa639ba1e9e3ffd9b9168ee07397bab15366353980",
                            "Explain": "①偶有错选C。儿茶酚胺作用于β受体，会增强Ca[SB2jia.gif]缓慢内流，使心肌收缩力加强，心率加速、房室传导加快。2相Ca[SB2jia.gif]内流增加，又导致外向K[SBjia.gif]流增大，3相复极加快，不应期缩短。低浓度普荼洛尔不影响心肌静息膜电位，但可阻断儿茶酚胺的上述作用。迟后除极由于细胞内钙浓度过高引起，因而普萘洛尔可减弱迟后除极，防止触发活动；②治疗浓度普萘洛尔能缩短普肯耶纤维的动作电位时程(APD)和有效不应期(ERP)，高浓度则延长。因此D为正确答案。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "阻断心脏β受体"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "降低窦房结、普肯耶纤维的自律性"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "降低儿茶酚胺所致的迟后除极幅度，防止触发活动"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "治疗剂量延长普肯耶纤维的APD和ERP"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "延长房室结的ERP"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007165,
                            "ATestID": 43007165,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "f461f9d3b7c6efcae2bf82d4b7fc501dacac8b6166ad3a0ff949513ac18928c3",
                            "Explain": "①常见错选A，原因是忽略了阿托品对不同器官解痉作用的差异。阿托品为M胆碱受体阻断药，具有较好的解除平滑肌痉挛作用，常用于内脏绞痛，但对胆道平滑肌痉挛缓解效果较差，单独应用效果不佳。它常与阿片类镇痛药合用以期产生协同作用，较好地缓解胆绞痛；②错选C，原因是仅考虑到哌替啶对各种疼痛有效，未考虑到哌替啶能提高平滑肌的张力，治疗浓度能使胆道平滑肌收缩，奥狄(Oddi)括约肌痉挛，胆汁排出受阻，致胆内压升高，可引起上腹不适甚至胆绞痛，因而对胆绞痛患者不宜单独应用。\n　　本题考查阿托品和哌替啶对胆道括约肌的作用，容易误选A或C，原因是对两种药物的作用了解的不全面，只注意了阿托品的松弛括约肌作用或哌替啶的镇痛作用。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "Content": "阿托品",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "阿托品+哌替啶",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "哌替啶",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "阿司匹林",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "滇丙胺太林",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007166,
                            "ATestID": 43007166,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "002235026aa4a922047aebb9b0059b87c0e8a7f78043fb2f7ebb66fc47b2af473a6328c83b83e8760367efd6a1cf8fef35b58e3a8f3e9614",
                            "Explain": "①错选D较多。原因：对受体的分布及其生理功能掌握不够。膀胱逼尿肌M受体兴奋表现收缩，括约肌M受体兴奋则表现舒张，故激动M受体可表现膀胱括约肌舒张；②错选E。瞳孔括约肌受胆碱能神经支配，故激动M受体可使瞳孔括约肌收缩，瞳孔缩小；③胃肠道括约肌收缩是肾上腺素能神经兴奋激动α受体的结果，故为本题答案。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "心率减慢"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "胃肠道平滑肌收缩"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "胃肠道括约肌收缩"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "膀胱括约肌舒张"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "瞳孔括约肌收缩"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007167,
                            "ATestID": 43007167,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "06081377796f4300bae458150973973a50f25431f8948cc93a6db2314c2cf701e25b4f5773879097b165635ebce1e32f",
                            "Explain": "吗啡成瘾性较强，所以人工合成了哌替啶替代吗啡，哌替啶成瘾性较吗啡弱。其他选项中①错选D。吗啡不能用于分娩止痛，其原因是：A.吗啡对抗催产素，使产程延长；B.吗啡可通过胎盘进入胎儿体内，由于吗啡有呼吸抑制作用，会造成新生儿窒息。哌替啶不对抗催产素，不会延长产程。哌替啶也能通过胎盘，新生儿呼吸抑制作用极为敏感，故产妇临产前2～4小时不宜使用，但非绝对禁忌，故此项正确；②错选C。对平滑肌两药作用基本相似，使张力增高，其中吗啡稍强，哌替啶弱些；③吗啡的成瘾性比哌替啶强，所以E项所述错误。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "吗啡的镇咳作用较哌替啶强"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "等效量时，吗啡的呼吸抑制作用与哌替啶相似"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "两药对平滑肌张力的影响基本相似"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "分娩止痛可以用哌替啶，而不能用吗啡"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "吗啡的成瘾性不比哌替啶强"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007168,
                            "ATestID": 43007168,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8bc821a9002ee90e95a69963e4af5bc8a1bcd27e50507e0938760a12f04468a8213e4eca6662c02712e4425ff294ba08203fcf90d7d08bb72327954b38d38fd6",
                            "Explain": "氯丙嗪所致帕金森综合征是由于氯丙嗪阻断了黑质多巴胺神经的受体，使纹状体功能相对占优势，肌张力增高，治疗应使用安坦，可阻断纹状体的胆碱能神经，使黑质-纹状体之间恢复平衡。阿托品虽然也属于抗胆碱药，但其脂溶性较低，不能穿过血脑屏障进入中枢，发挥不了治疗作用。由于氯丙嗪阻断多巴胺受体，此时应用补充多巴胺递质的左旋多巴是无效的。因此，答案选D。\n　　本题中考查氯丙嗪不良反应的治疗及抗帕金森病药的应用范围，容易误选A选项，由于帕金森综合征均为黑质功能降低，纹状体功能升高，因此治疗肯定是要提高黑质功能，抑制纹状体功能。而黑质发出的是多巴胺神经，纹状体发出的是胆碱能神经，所以药物而选项中由于多巴胺受体被阻断左旋多巴不能其作用，只能应用抗胆碱药抑制纹状体。阿托品虽然是抗胆碱药，但不能进入中枢，不能发挥作用。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "Content": "用多巴胺",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "用左旋多巴",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "用阿托品",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "减量，用安坦",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "用毒扁豆碱",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007169,
                            "ATestID": 43007169,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "303f4309e8a7112637fab074354029df44f076c135773f071ae46b7a38e55397e45f48037da515f1e574fb057ccf737680b521d9855f323fcb9b2b9cfc023699",
                            "Explain": "氯丙嗪的椎体外系反应是限制应用的主要原因，而一些新型的抗精神病药物此不良反应较轻，如氯氮平。①常见错选E。五氟利多的特点是长效抗精神病，疗效与氟哌啶醇相似，锥体外系不良反应仍常见；②氯氮平抗精神病作用较强，对其他药物无效的病例仍可有效。也适用于慢性精神分裂症。几无锥体外系反应。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "氯丙嗪"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "氯氮平"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "氟哌啶醇"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "氯普噻吨"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "五氟利多"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007170,
                            "ATestID": 43007170,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "482723ac8d6c96093730539ac169da63a6309f9976cbd760b3d1f04ee836f43fe8b96d1d1ad03268",
                            "Explain": "噻嗪类利尿药是临床广泛应用的一类口服利尿药和降压药。利尿作用机制是抑制髓袢升支粗段皮质部（远曲小管开始部位）NaCl的再吸收，产生中等效能的利尿作用。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抑制髓襻升支粗段髓质部和皮质部对NaCl的再吸收"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抑制髓襻升支粗段皮质部对NaCl的再吸收"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "抑制髓襻升支粗段髓质部对NaCl的再吸收"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "抗醛固酮作用"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "降低尿的稀释和浓缩功能"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007171,
                            "ATestID": 43007171,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "e7dab808552ef184e651e43b35178382abbe7302bbc97a2beb219132506bd888f1a5dd2fbbac4779565775c9997c447ef95a231ce3e40fd7",
                            "Explain": "①常见错选D。与司来吉兰混淆，司来吉兰为选择性单胺氧化酶B抑制剂，在脑内可使多巴胺代谢降低，使纹状体多巴胺增多；②溴隐亭对结节漏斗和黑质-纹状体通路的多巴胺受体有激动作用，对外周多巴胺受体激动作用较弱，治疗帕金森病的疗效与左旋多巴近似。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "中枢抗胆碱作用"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "激活DA受体"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "激活GABA受体"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "提高脑内DA浓度"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "使DA降解减少"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007172,
                            "ATestID": 43007172,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "02b50e5b583d09037e4f6f3813a2c4dc41f1b6c3ac77120fb7c246d70d8821093c631242caa54f4997ca69ef5a7ed981cf0257dcf3620d53e7f0c7f6ede3c1cb95d62ac6b30baacf433b5c0b585f2954ddd3fa240589daa5b4c60632903fc404cb7d608e65952e73322d707743e92769eb20ccc71dc3208880f16766dfb2da937324139045015f0705d1bc7a40f808e508695a6a04178305ea4aceb1fe146a7f9a85cf0a1f1e6ccb678906e7f68474bc5e0d7fc8c653e1325db8483aa39df434e99f15cf86b7e9f23d5a276f2c21c431bd47a7a7744b6b51",
                            "Explain": "呋塞米为高效能利尿药，能扩张肾皮质血管，增加肾血流量，增加尿量，对肾小管产生冲刷作用，防止肾小管萎缩，.急性或慢性肾衰时可用大剂量治疗。但无尿或严重肾功能损害者不宜应用。氢氯噻嗪为中效能利尿药，螺内酯和氨苯蝶啶为低效能利尿药，利尿作用均较弱，对于急性肾衰的进展均无作用。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "氢氯噻嗪"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "呋塞米"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "螺内酯"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "氨苯蝶啶"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "卡托普利"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007173,
                            "ATestID": 43007173,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "13b0623f14fec295658885a893f5237979906d4439cde83fea4db411f245d107f3830460f901c1df7596861f3f289dd19304666ce0302cd2",
                            "Explain": "利福平有广谱抗菌作用，对结核杆菌、麻风杆菌和革兰阳性球菌（金黄色葡萄球菌、链球菌、肺炎球菌）、革兰阴性球菌（脑膜炎球菌、淋球菌）有强大抗菌作用，对革兰阴性杆菌（大肠杆菌、伤寒杆菌、痢疾杆菌、绿脓杆菌）也有抑制作用。氨苄西林和青霉素对细菌具有杀灭作用，但对结核杆菌无效，而乙胺丁醇和异烟肼只对结核杆菌有效，其他细菌无效。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "氨苄西林"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "青霉素"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "乙胺丁醇"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "利福平"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "异烟肼"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007174,
                            "ATestID": 43007174,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "222375300d10e5ff1bde9d163fb332641ed847fb38d6f2cf8d3ffa2ff8f23b5f5360f94909cd0b35",
                            "Explain": "局麻药若剂量和浓度过高，或误将药物注入血管，使血中药物达到一定浓度时，可对中枢神经系统、心血管系统产生毒性反应。酯类局麻药如普鲁卡因其代谢产物在小部分人群中会产生过敏反应，故用前应作皮试。常用的局麻药利多卡因安全范围较大。丁卡因毒性大。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "利多卡因"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "普鲁卡因"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "依替卡因"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "丁卡因"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "布比卡因"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007175,
                            "ATestID": 43007175,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "05e894389d8c56be29ef4437e89ab0d9e2289e8ffd3383e94b03a160f10e7026cfd827eec13f7a35dd445dee285bc5e8bb56694f82683828d5b9db3abec93ada",
                            "Explain": "肝素的抗凝作用主要通过激活抗凝血酶Ⅲ，进而灭活多种凝血酶和凝血因子实现的。",
                            "TestPoint": "血液凝固、抗凝和纤溶",
                            "Answer": "C",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "拮抗维生素K"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "直接灭活凝血因子Ⅱa、Ⅶa、Ⅸa、Ⅹa"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "增强抗凝血酶Ⅲ的活性"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "直接与凝血酶结合，抑制其活性"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制凝血因子的生物合成"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007176,
                            "ATestID": 43007176,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "cbf38f524a6c8dbf8220ac08af03d9112fb0b61a0e51085f2c21a443f71a7eda3b437b90f6c9e31c",
                            "Explain": "地西泮临床应用于治疗：①焦虑症及各种神经官能症。②失眠：尤对焦虑性失眠疗效极佳。③癫痫：可与其他抗癫痫药合用，治疗癫痫大发作或小发作，控制癫痫持续状态时应静脉注射。④各种原因引起的惊厥。地西泮对精神分裂症无治疗作用。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "镇静"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "催眠"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "抗焦虑"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "抗精神分裂"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抗惊厥"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007177,
                            "ATestID": 43007177,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c3c80604e6441280de3eb72d92291bb942c3a007298bb11e0be2dfd042e650ccb6f2fb67b64cc0bfe0f4ea2170720bb3",
                            "Explain": "对血小板聚集的抑制作用：是通过抑制血小板内环氧酶、从而抑制血栓烷A[XB2.gif]的生成而起作用（TXA[XB2.gif]可促使血小板聚集）。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抑制血栓素A[XB2.gif]合成"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "促进前列环素的合成"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "促进血栓素A[XB2.gif]合成"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "抑制前列环素的合成"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制凝血酶原"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007178,
                            "ATestID": 43007178,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "58a57fe5f972bdf0a7954dc7598278b207b29492e954f26c4e0ab81ae74f6404b6678a20b47f4702ac7fc0430dda9aa51a5fdbb3fdcaccdc08c5373bec0ec1d6c9d2fccff1254f35",
                            "Explain": "利多卡因为窄谱抗心律失常药，只对室性心律失常有效，其作用能降低自律性，促进钾离子外流而缩短APD和ERP，抑制4相自动除极。对房室结无作用。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "使4相除极速率下降和减少复极不均一性，能提高致颤阈"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "促进细胞K[SBjia.gif]外流，缩短复极过程，且以缩短APD更为显著"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "对窦房结自律性没有影响，仅在其功能失常时才有抑制作用"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "减慢房室结传导"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "降低自律性"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007179,
                            "ATestID": 43007179,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "24b70613a3a1d11d8388a9e62f2b94183803ce1380963034bde631a611ddd1339902dd73bb5faaedb2653b43d80ffea27669a9faa47ed96b",
                            "Explain": "HMG-CoA还原酶抑制剂为他汀类调血脂药，能抑制肝脏合成胆固醇的关键酶HMG-CoA还原酶，抑制胆固醇合成从而降低胆固醇。苯氧酸类也称贝特类，主要降低甘油三酯和极低密度脂蛋白（B选项）；抗氧化剂可防止氧化自由基对脂蛋白的修饰，抑制动脉粥样硬化的形成和发展（C选项）；胆汁酸结合树脂可通过减少胆汁酸的吸收而消耗胆固醇，也为主要降低胆固醇药物，但其作用没有HMG-CoA还原酶抑制剂作用强（D选项）；烟酸为主要降低甘油三酯药物（E选项）。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "HMG-CoA还原酶抑制剂"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "苯氧酸类"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "抗氧化剂"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "胆汁酸结合树脂"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "烟酸"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007180,
                            "ATestID": 43007180,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "02b50e5b583d0903e9bdb7a0c199b152faad31696e62a2fe34961874f825564679fad84c84ad6a930bb30643648cebb9eeb9b6242677f1f97c4e39dcb38f35d42f0d680cb5d7a427d984bd376570b9aa7b0eca2b33e7d8013bed4b771bc98f0d3c2151d09eb21fb5befc31bd0cddebabe2b893b08aefc9dd024a5a619c3560d585c8c1dd49ed7d87215d4e925547a968e071c8fac8ae7f78934a712fd528c7ace430b2cba00200e921110d5f873d0d71fe6b80d51b92dc429d2c2134e2d8f9aca0d50d285ab4f86629c4d53ad6cad5fe050d94b04ce5579d20cedb903d203a74",
                            "Explain": "患者有甲亢病史，心率较快，同时有心肌缺血改变，适宜应用β受体阻断药，同时对此三种病理改变有作用。其他药物均为单纯抗心律失常药，对甲亢和心肌缺血均无治疗作用，胺碘酮还可导致甲状腺功能异常，因此均不能选用",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "胺碘酮"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "奎尼丁"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "普鲁卡因胺"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "普萘洛尔"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "利多卡因"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007182,
                            "ATestID": 43007182,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8bc821a9002ee90e47383e352d297c19c255731f64e7ec8dce81946126280a66c8a92f5fe19d02bb551769c563bb035ac9b6ced07f753c95834cdb2e5e08c85c60a38b9fc738f988e489ebd0f6632cc730743d2f125625d7",
                            "Explain": "氯丙嗪降压是由于阻断α受体。肾上腺素呵激活α与β受体产生心血管效应。氯丙嗪中毒引起血压下降时，用肾上腺素后仅表现β效应，结果使血压更为降低，故不宜选用，而应选用主要激动α受体的去甲肾上腺素等。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "有抑制血管运动中枢作用"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "直接扩张血管平滑肌"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "可阻断α受体"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "可阻断β受体"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "可阻断M受体"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007183,
                            "ATestID": 43007183,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "a1f46dc1ce93ce94e5b0403a1bd613f94fa0b338848ee5501215c055b955fa9d2974a016f490d2c6",
                            "Explain": "①错选B发生率高。其原因对本类药作用机制理解不够。有实验证明，给动物分别注射大肠杆菌和PG均可使体温升高。本类药对注射大肠杆菌之动物有解热作用，而对注射PG的动物则无解热作用，故认为它是抑制PG的生物合成；②膜磷脂在磷脂酶A[XB2.gif](PLA[XB2.gif])作用下生成花生四烯酸，在环氧酶(COX)作用下生成PG。本类药物抑制COX，而使PG生成减少发挥作用解热镇痛抗炎作用。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "减少前列腺素(PG)释放"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "对抗PG作用"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "抑制环氧酶(COX)"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "抑制MAO"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制AchE"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007184,
                            "ATestID": 43007184,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "ddf33b927f928156160cac17e556e042da873fa3277f9ac762a327584db43ff72baaf927b6a2150def6eaae12b9d8f328582fb0493a24433bb53365a1f293c37aaf90507b4af5480",
                            "Explain": "肾上腺素对各部位血管的效应不一致，以皮肤黏膜血管收缩为最强烈；内脏血管，尤其是肾血管，也显著收缩；对脑和肺血管收缩作用十分微弱，有时由于血压升高而被动地舒张；骨骼肌血管β[XB2.gif]受体占优势，故呈舒张作用。去甲肾上腺素和间羟胺为α受体激动药，只激动血管α[XB1.gif]受体，对皮肤黏膜、骨骼肌血管均具有收缩作用。普萘洛尔为β受体阻断药，对血管产生收缩作用。异丙肾上腺素为β受体激动药，对皮肤黏膜和骨骼肌的血管为舒张作用。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "NA"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "普萘洛尔"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "肾上腺素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "异丙肾上腺素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "间羟胺"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007185,
                            "ATestID": 43007185,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "06081377796f430041d48edf208649511f646dcf0b5c1939",
                            "Explain": "吗啡类有强大镇痛作用，能在不影响意识和感觉的情况下明显消除痛觉反应，对各种原因引起的疼痛均有效，由于易成瘾，不用于慢性钝痛，用于治疗其他镇痛药无效的急性锐痛。由于吗啡能通过胎盘抑制胎儿或新生儿呼吸，同时能对抗催产素对于子宫的兴奋作用而延长产程，故不用于分娩镇痛，吗啡兴废胃肠平滑肌和括约肌，提高其张力，甚至达到痉挛的程度，故不用于胃肠绞痛和肾绞痛。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "慢性钝痛"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "急性锐痛"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "分娩镇痛"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "胃肠绞痛"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "肾绞痛"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007186,
                            "ATestID": 43007186,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "9b9432a4cee3c55b5cebb8dc9468d613490126fc9080514cedffe688646dce25ea83eb9818ffa5f4",
                            "Explain": "毛果芸香碱直接的选择兴奋M胆碱受体，产生与节后胆碱能神经兴奋时相似的效应。它对眼和腺体的作用最明显，具有缩瞳、降低眼内压和调节痉挛等作用，另外，可使汗腺、唾液腺分泌明显增加。",
                            "TestPoint": "胆碱受体激动药",
                            "Answer": "D",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "阻断虹膜α受体，开大肌松弛"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "阻断虹膜M胆碱受体，括约肌松弛"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "激动虹膜α受体，开大肌收缩"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "激动虹膜M胆碱受体，括约肌收缩"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制胆碱酯酶，使乙酰胆碱增多"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007187,
                            "ATestID": 43007187,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "9a6f14326814c1e0807d17a7a26df6da9cdc583e760ca2fee192974ffa2c958b63be161156049324ad273505e1be3783267bb4c07229ac95",
                            "Explain": "甘露醇为脱水药，应用后可增加血管内渗透压，使水肿脑组织的水由脑细胞进入血管，抑制脑水肿。利尿作用为进入肾小管后，增加肾小管腔内渗透压，抑制水的重吸收而产生利尿作用，因此其利尿作用为渗透性利尿。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "水利尿"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "排钠性利尿"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "保钾性利尿"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "渗透性利尿"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "排钾性利尿"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007188,
                            "ATestID": 43007188,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "966b1f4dabde7a36e5470c7bc4078dfef7ec6149ee1c19db48749e67e6708319bc0a5f9f500e21235f9fe356e847ce2a5313ab3397c14ca8",
                            "Explain": "酚妥拉明为α受体阻断药，通过阻断血管平滑肌的α受体而具有非常强的舒张血管作用，用于血管痉挛性疾病。常见错选A。山莨菪碱能解除微血管痉挛，有良好的抗休克作用，对外周血管痉挛缓解差，不用于外周血管痉挛性疾病。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "山莨菪碱"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "异丙肾上腺素"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "间羟胺"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "普萘洛尔"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "酚妥拉明"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007189,
                            "ATestID": 43007189,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "adfb45b9865321ccf319c495a479f5b192f7b6c922e1cfa410f6dc92aad3046783c76ed94c40492ee90b4b21499a9ed4",
                            "Explain": "①错选D。普萘洛尔具有膜稳定作用，只是在一般的临床剂量下难以表现出来，需要很大的剂量才能发生膜稳定作用；②错选B。β受体阻断药口服后自小肠吸收，但由于受脂溶性高低的影响及通过肝脏时的首关消除，其生物利用度差异较大，如普萘洛尔口服首关消除率60-70%，生物利用度仅为30%，而生物利用度低，此项也是普萘洛尔所具有的作用。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "阻断心脏β[XB1.gif]受体及支气管β[XB2.gif]受体"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "生物利用度低"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "抑制肾素释放"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "膜稳定作用"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "内在拟交感作用"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007190,
                            "ATestID": 43007190,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "32e612bbfea029f2fd30d3f62a981ae82a5c3b489f7089f78041c0f3db2d8bbd1496e125f215601ff7b7241162e8974b4d7afc2a9e4b98ed",
                            "Explain": "下列四环素类药物中，抗菌作用最强的是米诺环素。",
                            "TestPoint": "四环素类抗生素",
                            "Answer": "A",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "米诺环素"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "多西环素"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "四环素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "土霉素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "金霉素"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007191,
                            "ATestID": 43007191,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "e6c480f3d31da7c6700f2c0658929a6cc30d71ec9558518dc91807f716f41337eb3c1f4bd0fb83490b1609e6c5ff51666607fe02243c742b1903e38f3d00b88e2e7070be14f3a1c02b9bfa186625eab4",
                            "Explain": "磺胺类药物中，磺胺嘧啶血浆蛋白结合率最低，进入血液后大部分以游离形式存在，容易穿透各种膜进入组织。因此，在治疗流行性脑脊髓膜炎时选用磺胺嘧啶，其游离形式较多，更容易穿透血脑屏障进入脑组织。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "磺胺二甲基嘧啶"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "磺胺甲唑"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "磺胺嘧啶"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "磺胺间甲氧嘧啶"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "磺胺米隆"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007192,
                            "ATestID": 43007192,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0aed7a30e9b3659b44b90f87848f2a23585d1d196ff65f9bbf3c0dfb3f6f10dd72e9a9a218153281973b3285fe146ddc969fe7d5f49c3b43",
                            "Explain": "异烟肼对结核杆菌具有高度选择性和强大的杀灭作用，是治疗活动性结核的首选药。异烟肼单独应用易产生耐药性，但停用一段时间后可恢复对药物的敏感性，临床常采用联合用药以增加疗效和延缓耐药型的产生。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抗结核作用强大"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "穿透力强，易进入细胞内"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "结核菌不易产生耐药性"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "对结核菌有高度选择性"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "有杀菌作用"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007193,
                            "ATestID": 43007193,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "015b76d514fdac07991fcc7aac4a6ef1dfdcd03aaca9fa1a4b3b63e0196fdc824d07e0555d0f719c",
                            "Explain": "氯喹为控制疟疾症状药物，能杀灭红细胞内的裂殖体，有效控制疟疾的临床发作，但对子孢子、休眠子和配子体无效，不能用于病因预防以及控制远期复发和传播。因此，氯喹不能用于疟疾的根治性治疗。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "是用于控制症状的抗疟药"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "可以根治间日疟"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "对间日疟原虫和三日疟原虫以及敏感的恶性疟原虫红细胞内期裂殖体有杀灭作用"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "具有在红细胞内浓集的特点，有利于杀灭疟原虫"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "不能用于病因学治疗"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007194,
                            "ATestID": 43007194,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c8ad0cd9e5f79743218400551894ed7eb2d782721997a4df7814470d0b66f55e0d13e5ce2ac34a2ca1ebe67886acb9da4b62110438b51315",
                            "Explain": "选项中A、B、C、D均为对急性炎症早期的作用，能减轻炎症早期红、肿、热、痛等症状，减轻炎症对对组织的损伤。对于慢性炎症可抑制肉眼芽组织，防止粘连和瘢痕，但也可延缓伤口的愈合。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "具有强大抗炎作用，促进炎症消散"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抑制花生四烯酸释放，使炎症介质PG合成减少"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "促进炎症区的血管收缩，降低其通透性"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "稳定溶酶体膜，减少蛋白水解酶的释放"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制肉芽组织生长，防止粘连和瘢痕"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007195,
                            "ATestID": 43007195,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0bf0db2ec76acb6cf38674a3ceb5d08ef176332185f33e6ff0fc491c648ab5e1e039e9c1441fe6712a8ebd2c562d01379a3529211d04e770",
                            "Explain": "硝酸甘油具有扩张血管作用，可使血压降低，从而激动颈动脉窦和主动脉弓的压力感受器，反射性的兴奋交感神经，使心率加快。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "扩张脑血管"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "扩张冠状血管"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "心率减慢"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "扩张静脉"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "降低外周阻力"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007196,
                            "ATestID": 43007196,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "a50245ed3db7bc4c4ac0756fa15f92f24f31053879bd1536e8af4cbbac59c3759158641a91685b4408ce0cdb065ff0eb445404901f9198a8",
                            "Explain": "去甲肾上腺素对β[XB2.gif]受体几乎无兴奋作用，用药后冠脉的扩张主要是其激动心脏β[XB1.gif]受体，心脏兴奋后，心肌代谢产物如腺苷等增加，从而使冠脉扩张。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "激动β[XB2.gif]受体"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "激动M胆碱受体"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "使心肌代谢产物增加"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "激动α[XB2.gif]受体"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "以上都不是"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007197,
                            "ATestID": 43007197,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "7701d8c7218964bd8605ec17cdf30cce372cb3c123cd8cd9b7670a43f2b73297d6b0eb509e8dc74b",
                            "Explain": "新斯的明是可逆性胆碱酯酶抑制药，可用于骨骼肌进行性肌无力的重症肌无力，可改善肌无力症状。本品还能兴奋胃肠道平滑肌和膀胱逼尿肌促进排气和排尿，可用于手术腹气胀和尿潴留。此外通过拟胆碱作用使心率减慢，用于阵发性室上性心动过速并可解救除非极化型肌松药如筒箭毒碱过量中毒。毒扁豆碱和毛果芸香碱也为拟胆碱药，但其主要作用于眼睛，对其他平滑肌作用较弱，不用于术后腹气胀。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "阿托品"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "东莨菪碱"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "毒扁豆碱"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "新斯的明"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "毛果芸香碱"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007198,
                            "ATestID": 43007198,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "e246f9f74ea071a07f9478a08e403ff4ce25c77717780fadddfa05cab06a6711e0f8758d73040d8dcbf9ed771382eb65a761cd6ca52e5488976e2bc1f9278f3b",
                            "Explain": "苯二氮[caozhuo.gif]类药物虽然对快动眼睡眠影响较小，停药后虽然不容易引起反跳性快动眼睡眠时相延长而对药物产生依赖，但长期应用也非绝对不产生对药物的依赖，并产生耐受性，导致药物作用明显下降。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "Content": "是最常用的镇静催眠药",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "治疗焦虑症有效",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "可用于小儿高热惊厥",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "可用于心脏电复律前给药",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "长期用药不产生耐受性和依赖性",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007199,
                            "ATestID": 43007199,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "71faf134f78c599e7f5bcd4ffa4289d002c3b371a96b4d63e6a05195c9a0cf2ad8f97703e8714100dfc4859ca02a39f9442d7cd8129a03df77e0894ca17a2ddc",
                            "Explain": "多巴胺除能直接激动心脏β[XB1.gif]受体，增强心肌收缩力，增加心排出量外，尚能选择性激动血管平滑肌的多巴胺受体，引起肾血管和肠系膜血管扩张，增加肾血流量和肾小球滤过率，使尿量增加。麻黄碱和肾上腺素为α、β激动药，皮肤黏膜和包括肾脏在内的内脏血管主要以α受体占优势，产生收缩作用。异丙肾上腺素虽然也扩张肾脏血管，但由于其扩张外周血管导致血压降低，使肾脏灌注压下降，肾脏的有效血流量并不增加。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "麻黄碱"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "多巴胺"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "肾上腺素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "去甲肾上腺素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "异丙肾上腺素"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007200,
                            "ATestID": 43007200,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0471aa097847771e93f05580c8b2db522b748f9bd9e91b3d7b2824d82849fcc17d66948231202353",
                            "Explain": "本题容易误选C，维拉帕米为Ca[SB2jia.gif]拮抗剂，虽然也有抑制心脏、降低心率作用，但在整体下，由于阻滞Ca[SB2jia.gif]内流，血管扩张，血压下降，压力感受器刺激减弱，交感张力增强，会抵消一部分维拉帕米对窦性频率的直接影响，窦性频率并不明显减慢，故对窦性过速疗效不如普萘洛尔。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "美西律"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "苯妥英钠"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "奎尼丁"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "普萘洛尔"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007202,
                            "ATestID": 43007202,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0131cb44e00bc3f8abe1a63a72e0cffe676d1cbc479d0df7f243f2a8576a118e66ccf7c06977a674a5569ccef3cb7e04001f6f6d1e776d5b",
                            "Explain": "不能正确回答的原因是对强心苷中毒的机制不掌握所致。强心苷过量中毒会严重抑制Na[SBjia.gif]-K[SBjia.gif]-ATP酶，由于酶的抑制，使细胞内Na[SBjia.gif]浓度增高，K[SBjia.gif]浓度降低。胞内Na[SBjia.gif]量增多后，又通过Na[SBjia.gif]-Ca[SB2jia.gif]双向交换机制使Na[SBjia.gif]外流增加，Ca[SB2jia.gif]内流增多，或使Na[SBjia.gif]内流减少，Ca[SB2jia.gif]外流减少，最终导致胞内Na[SBjia.gif]浓度下降，Ca[SB2jia.gif]浓度上升，后者又使肌浆网摄取Ca[SB2jia.gif]增多，储存增多。故中毒时，心肌细胞Ca[SB2jia.gif]浓度过高，K[SBjia.gif]浓度过低。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "心肌细胞内K[SBjia.gif]浓度过高，Na[SBjia.gif]浓度过高"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "心肌细胞K[SBjia.gif]浓度过高，Na[SBjia.gif]浓度过低"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "心肌细胞Mg[SB2jia.gif]矿十浓度过高，Ca[SB2jia.gif]浓度过低"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "心肌细胞Ca[SB2jia.gif]浓度过高，K[SBjia.gif]浓度过低"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "心肌细胞K[SBjia.gif]浓度过高，Ca[SB2jia.gif]浓度过低"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007203,
                            "ATestID": 43007203,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "ef441a0b4119885ae8bbbad47a6988dffd62cece5439ef500ee84b8c91d610ddb5d5d926e132819283c83bc0473d83b4",
                            "Explain": "乙酰胆碱是一种神经递质，能特异性的作用于各类胆碱受体，在组织内迅速被胆碱酯酶破坏，其作用广泛，选择性不高。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "被单胺氧化酶所"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "被氧位甲基转移酶破坏"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "被磷酸二酯酶破坏"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "被胆碱酯酶破坏"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "被神经末梢再摄取"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007204,
                            "ATestID": 43007204,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "55dc07c48b2f9c2262902f379bc38358978435d4038f062e138eb6f3d74a7fda07fd611fb58d58d85e30529516519b7ddf2f3556596982ed",
                            "Explain": "①错选A。室性早搏是由于普肯耶纤维Na[SBjia.gif]-K[SBjia.gif]-ATP酶的抑制，细胞内失K[SBjia.gif]，而致自律性增高。过速型心律失常，最常见的是室性早搏，故是补钾的适应证；②房室传导阻滞者不可给钾盐，因K[SBjia.gif]会进一步加重房室传导阻滞。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "室性早搏"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "室性，心动过速"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "室上性阵发性，心动过速"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "房室传导阻滞"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "以上均可以"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007205,
                            "ATestID": 43007205,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "4b6146b7a7091df4725840de7da6b718c1be690f9e4b1f7ad8573a11c57001e6",
                            "Explain": "氯沙坦为血管张紧素Ⅱ(ATⅡ)受体拮抗药，具有良好的抗高血压、逆转心肌肥厚的作用，氯沙坦及其活性代谢物能有效阻断血管紧张素Ⅱ与ATⅡ受体的结合即拮抗ATⅡ受体活性，降低外周血管阻力，使血压下降。但其对血管紧张素转换酶(ACE)无抑制作用，因此也对缓激肽的降解无影响。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "拮抗ATⅡ受体活性"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "拮抗ACE的活性"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "拮抗肾素活性"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "减少血液缓激肽水平"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "增加血液血管紧张素Ⅱ水平"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007207,
                            "ATestID": 43007207,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "f3bdbfebc6fe7e93612e3f1d1ca7c51e270ad737fc308cc252c99947185090ab",
                            "Explain": "用药剂量过大、用药时间过长或机体对药物敏感性过高时产生的危害性反应称为毒性反应。毒性反应的类型、严重程度主要取决于毒物的理化性质、接触状况、生物系统或个体的敏感性。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "一种过敏反应"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "在使用治疗用量时所产生的与治疗目的无关的反应"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "因用量过大或机体对该药特别敏感所发生的对机体有损害的反应"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "一种遗传性生化机制异常所产生的特异反应"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "指剧毒药所产生的毒性作用"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007208,
                            "ATestID": 43007208,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "939c1453c70bf185ac303012378ac43c1d87857af7d591af9841ccb599598e68d1ec2a2cc7fc73acf884ef9da331b1191745c079b353695f5926e619e226b624",
                            "Explain": "碘解磷定等解毒药在体内能与磷酰化胆碱酯酶中的磷酰基结合，而将其中胆碱酯酶游离，恢复其水解乙酰胆碱的活性，故又称胆碱酯酶复活剂。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "能阻断M胆碱受体的作用"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "能阻断N胆碱受体的作用"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "能直接对抗体内积聚的ACh的作用"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "能恢复AChE水解ACh的活性"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "能与AChE结合而抑制酶的活性"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007209,
                            "ATestID": 43007209,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "35b94ff0f5d9cd0c9ca6987ff270916f3d6db773bd8b9f165ddc3d26b27eca776a74303ae71d9a2ad57c32f507e4e9bcafe612914bcd8562",
                            "Explain": "①常见错误为选A。本类药口服吸收完全，如华法林口服1小时血中即能测得，2小时可达高峰，吸收并不慢；②显效慢的原因与其作用机制有关。本类药是维生素K拮抗剂，在肝脏抑制维生素K由环氧化物向氢醌型转化，从而阻止维生素K的反复利用，影响含有谷氨酸残基的凝血因子Ⅱ、Ⅶ、Ⅸ、Ⅹ的羧化作用，使这些因子停留于无凝血活性的前体阶段，从而影响凝血过程。对己形成的上述因子无抑制作用，因此，抗凝作用出现慢。一般8～12小时后发挥作用，1～3天达高峰，停药后抗凝作用可持续数天。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "吸收慢"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "生物利用度低"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "药物与血浆蛋白结合的百分比高"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "对体内原有的活化凝血因子无影响"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "半衰期长"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007210,
                            "ATestID": 43007210,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "6caf0e08305ae0937af97a4a2554f589",
                            "Explain": "阿托品竞争性拮抗ACh或胆碱受体激动药对M胆碱受体的激动作用。通过M胆碱受体的阻断作用抑制腺体分泌，对胃肠道平滑肌、尿道和膀胱逼尿肌等多种内脏平滑肌有松弛作用，扩瞳、眼内压升高和调节麻痹，治疗量阿托品单独使用时对血管与血压无显著影响。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "能促进腺体分泌"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "能引起平滑肌痉挛"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "能造成眼调节麻痹"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "通过加快ACh水解发挥抗胆碱作用"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "作为缩血管药用于抗休克"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007211,
                            "ATestID": 43007211,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c8ad0cd9e5f797435f873107800ee415f3e7fcaed812bbe3ac9ddacdec163ac21df85096f2e9c9b7ad7beb13357a27c4cd57cd3d8ad5f607",
                            "Explain": "糖皮质激素为抗炎药，对于炎症早期的红肿热痛等症状和晚期的炎症修复作用均具有抑制作用，但同时炎症也是对抗感染扩散的屏障，可通过炎症细胞吞噬细菌等机制发挥抗感染作用。因此，糖皮质激素可通过抑制炎症而可能导致感染扩散。同时，糖皮质激素还具有抗免疫作用，降低机体的抵抗力。因此可诱发或加重感染。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "用量不足，无法控制症状而造成"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "病人对激素不敏感而未反映出相应的疗效"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "促使许多病原微生物繁殖所致"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "抑制炎症反应和免疫反应，降低机体的防御能力"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制促肾上腺皮质激素的释放"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007212,
                            "ATestID": 43007212,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c8ad0cd9e5f7974383ec17887de43a8de5df1013f5d462d09ed596c838aeb32670156ec83a067c1d2862ad3d2cc8808eca7be5370c508fcd",
                            "Explain": "糖皮质激素具有刺激骨髓造血作用，使大多数血细胞数量增加，包括红细胞、血红蛋白、中性粒细胞、血小板等，但淋巴细胞数量是减少的。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "使中性粒细胞减少"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "使血小板减少"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "刺激骨髓造血功能"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "淋巴细胞增加"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "使红细胞与血红蛋白减少"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007213,
                            "ATestID": 43007213,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "b931904abaea818580e5260c6ff1933e1f34965ec1c4a3da1d4fe667830a758fd064a417ac676e20",
                            "Explain": "红霉素、克拉霉素、阿奇霉素以及罗红霉素均属大环内酯类的药物，而林可霉素属于林可霉素类抗生素。",
                            "TestPoint": "大环内酯类抗生素",
                            "Answer": "B",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "红霉素"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "林可霉素"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "克拉霉素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "阿奇霉素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "罗红霉素"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007214,
                            "ATestID": 43007214,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "212f5f8e5b240d677658f4ed01f850e16920ce5f3d7fde507c409ada9914487dcffd4201016d8245",
                            "Explain": "常见错选C。虽然氨基苷类对革兰阳性菌差，但某些品种（如庆大霉素、西索米星）对产青霉素酶的金葡菌敏感。对革兰阴性球菌、脑膜炎球菌作用较差。对各型链球菌、肠球菌、各种庆氧菌则耐药。因此E是答案。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "对革兰阴性菌作用强"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "对淋球菌作用差"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "对耐青霉素金葡菌敏感"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "对静止期细菌亦敏感"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "对厌氧菌敏感"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007215,
                            "ATestID": 43007215,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "a593b220ce5a7c981546556da2f54d0e00ae7e5d9b27c51b24047813539173fb97c1c8bd0d57b0b5321a886d56e9e6f9e559cb3b4803fe1c28c70e553e5d3920a567705d60e203aefbd3d4bcf7eb421d4bf5752caedcde84b32ecd5af9795ec5facef59812ca0ab57199c9c1be29f7be953d23764dc3053111cb7887e7b89cc90a3bbd78512cae5ee07a35f02d9dab1139207b036e3e4cdbffa3513db72fce75",
                            "Explain": "喹诺酮类抗菌药可引起软骨损害，影响胎儿或婴幼儿发育，故不宜常规用于儿童，禁用于孕妇和哺乳期妇女。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "青霉素类"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "头孢菌素类"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "β-内酰胺类"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "红霉素类"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "喹诺酮类"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007216,
                            "ATestID": 43007216,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c0d1b4101263662998e7df6dee57377c97a86f78cd68b7a8ed771e5154a4ae02f60a86152377f3e9de330efd880221cf86a6047972c294dc",
                            "Explain": "四环素类药物的不良反应主要表现为以下几个方面：（1）胃肠道反应 恶心、呕吐、腹痛、腹泻、严重时可引起伪膜性肠炎。以金霉素为最显著，其次为四环素，土霉素反应较轻。（2）肝脏毒性 大剂量口服或静脉注射时常可损害，表现为恶心、呕吐、发热、黄疸、转氨酶升高，严重者可致肝功衰竭，以至死亡，尤其对孕妇或伴肾功能不全者更易发生。（3）对骨、牙组织损伤 学龄前儿童用药可致牙齿黄染，釉质发育不全，俗称：“四环素牙”。孕妊用药可使胎儿牙齿黄染；还可抑制早产儿骨骼生长。（4）肾损害 肾功不全者可致氮质血症和尿毒症。（5）过敏反应 可致各种过敏性皮疹、皮炎、舌炎和阴道炎。（6）双重感染 发生率较高，其中以抗生素相关性肠炎、真菌性肠炎最为多见。（7）其他 四环素静滴可致静脉炎，组织坏死，肢体疼痛等。米诺霉素可引起耳前庭功能紊乱。没有内分泌紊乱。",
                            "TestPoint": "四环素类抗生素",
                            "Answer": "D",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "二重感染"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "胃肠道反应"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "牙齿黄染"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "内分泌紊乱"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "过敏反应"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007217,
                            "ATestID": 43007217,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "002235026aa4a922d37ef7e13c6443529f1065dd219ff38f87a9eedaea50eda98bd67740a39c57fe",
                            "Explain": "①常见错选C，对概念未充分理解。其概念是：有些药物首次通过肝脏就发生转化，减少进入体循环的量，称为首关消除。选C者未强调首次经肝代谢，只强调了吸收入血的量减少；②错选B。答案虽强调了经肝代谢，但并非首次通过肝脏。因为舌下含药，经口腔黏膜吸收入腔静脉，进入体循环后人肝，故也不准确。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "苯巴比妥钠肌注后被肝药酶代谢，使血中浓度降低"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "硝酸甘油舌下给药，自口腔黏膜黏膜吸收，经肝代谢后药效降低"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "青霉素口服后被胃酸破坏，使吸收入血的药量减少"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "普萘洛尔口服，经肝代谢，使进入体循环的药量减少"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "以上都是"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007218,
                            "ATestID": 43007218,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "484595542b730062fe107de955b6e18fa3b6341b615adeb0bea0bb150850245c9a8dfd823284fadadc9c503e02a68fc09160715054a4c32041fb14be1367ff44",
                            "Explain": "常见错误为选D。0相是Na[SBjia.gif]内流所致，0相除极的速度和幅度决定了传导性，故减慢传导是正确的。同时由于减慢传导会变单向阻滞为双向阻滞，加重阻滞，也是正确的，但不是发挥治疗作用的主要原因。由于发生了阻滞而消除了折返激动才是治疗作用，因为“折返激动”是引起心律失常的重要机制之一。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "改善传导，取消单向阻滞"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "降低自律性，取消异位节律"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "减慢传导，取消折返激动"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "减慢传导，加重阻滞"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "缩短不应期"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007219,
                            "ATestID": 43007219,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "72a0b4c5d55ebb1f0d53a47f480c4c16ed8e95f0d5c1f7482299cf2c402b758834c30af090441b72e7d6549264b7f93bddc2f23ddbe392858f9ea675c9415aec79247309582f9f9f",
                            "Explain": "(1)错选A。①噻嗪类利尿药属于中效利尿药，不适用于高血压危象这种急症；②噻嗪类对肾功衰竭无治疗作用。(2)呋塞米是高效、速效利尿药，可使血容量立即减少，可缓解高血压危象，同时可增加肾皮质血流量，改善肾功，故选用呋塞米较适宜。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "噻嗪类利尿药"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "呋塞米"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "可乐定"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "螺内酯"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007221,
                            "ATestID": 43007221,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "55dc07c48b2f9c2205c31a64d3b87c86b7ff830c7e04e72761ba6dd78f216778a3f9759eb2d210c2",
                            "Explain": "①错选A。肺源性心脏病的原发病是肺功能不良，呼吸困难，机体乏氧。在乏氧情况下，强心苷易中毒。此项是适应证，但不是“最好”。应用时，剂量要小，以防中毒；②严重贫血病人，心肌能量产生障碍。强心苷可以改善心功能，但不能改善能量的产生，故C不是最好适应证；③高血压心衰，是由于血压的增高，心脏负担加重，而发生心功能的失代偿，强心苷基本作用为增强心肌收缩力，可很好纠正高血压心衰。同时，心房颤动也是强心苷的适应证之一，强心苷减慢房室传导可减少房颤引起的心室频率过快，故最有效。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "肺源性心脏病引起的心衰"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "严重二尖瓣病引起的心衰"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "严重贫血引起的心衰"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "甲状腺功能亢进引起的心衰"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "高血压性心衰伴房颤"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43007222,
                            "ATestID": 43007222,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 2,
                    "Style": "A2型题",
                    "Explain": "A2型题：每一道考题是以一个小案例出现的，其下面都有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 5,
                    "TestItems": [
                        {
                            "Title": "72a0b4c5d55ebb1ffa5ae1c018c0fbb7e145e78860765a8ac2d085470bcb4f0da304c359ad4f969bd8710e872a104ef2704e1c10e622cc88bddfad29ca80f885919ca5522565975feed0b5256d544f4a4222cad3a6b47b5d9164e35f2bba4e2c0ecfd195332c991b",
                            "Explain": "本题考核\"抗高血压药的选择应用\"。高血压伴心绞痛、哮喘及肾功能不全的患者，选用药物要依据并发症和各抗高血压药物的药理学基础。最合适的治疗药是钙拮抗药硝苯地平，其对小动脉、小静脉、缺血冠脉、肾血管等都有扩张作用，减轻心前、后负荷，还轻度松弛支气管，用于降压、心绞痛及改善哮喘且不影响肾功能。卡托普利是血管紧张素转换酶抑制剂，可使血管扩张、血压下降，因降低心前、后负荷，用于降压，改善心绞痛，但对支气管平滑肌无影响，对肾功能不全者易引起高血钾。β受体阻断药普萘洛尔，因阻断支气管和肾血管β[XB1.gif]受体，可诱发或加重哮喘和肾功能不全。利尿药氢氯噻嗪对哮喘和心绞痛无治疗作用，还可降低肾小球滤过，对肾功能不全患者不利。哌唑嗪选择性对突触后膜α[XB1.gif]受体阻断，使小动脉、小静脉及肾血管舒张，血压下降，还因降低心前、后负荷，有利于改善心绞痛，但对支气管平滑肌无舒张作用。考生选择硝苯地平为最适合治疗的药物者占26.4%。其他考生没有对并发症和药物作用、应用进行全面分析比较，选择了其他不适合或禁用的药物。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "卡托普利"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "普萘洛尔"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "氢氯噻嗪"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "哌唑嗪"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023482,
                            "ATestID": 43023482,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "6a96c408001e3650537a9c1319bd84d6728d45c76f8e3e9d59ccbbbf06ad02f4d53d04c9c21be0851273daa80a952299a4545bc3254ba0381d17d9f16c2a5596a3db8167bff1d675c39c3491bcafe379f1344f68e9210bacbd77c34862b0900894038675cf0428d56f0c4da16a7fd3ef2f9c587a76975a0b3bfaef7128f03193f2f8dc586cf5becf1f6dccf1e4d04f5b",
                            "Explain": "此题是理解分析试题，考核\"利尿脱水药的选择应用\"。头部外伤引起颅内压升高，应选择利尿脱水作用快而强的药物。备选药物中，3个属高效利尿药，作用强、快，可降低颅内压，但不良反应大。螺内酯是抗醛固酮的利尿药，作用出现慢，利尿弱，故不能迅速有效降低颅内压。甘露醇静滴具有高渗脱水利尿作用，可迅速降低颅内压，是常用安全有效的首选药。综上比较，螺内酯不宜用于颅内压升高。选择此正确答案考生占47.9%，显示题目难度中等。其他考生选择的呋塞米、布美他尼和依他尼酸都有强大的利尿作用，排泄大量水分，血液浓缩有助于消除脑水肿。选择这些药物的原因是仅片面从不良反应考虑，导致不恰当的选择。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "呋塞米"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "甘露醇"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "螺内酯"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "布美他尼"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "依他尼酸"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023483,
                            "ATestID": 43023483,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "64f049a76ce3689213de09479a442f355d4d18ac25a9fc18ef1b3166b6bf3aa320a59ddeb334b65167178156f6f6db075a2c2a018b5b8a7d56b509715300515c8f341d49d6443abdc04e4efc0e9778f28c81f5e02b1b3e9757206e0244e7d690bf7c8bbfdf1acd977391851ad3e7dc9dd2f17fea08a5956c7e674afcd9ed49fa611fac71048fe5609d3c2e61f55815fc818497eebff405d8118f74556bbaeaf195102300a25a4353235c261a8a9a9364",
                            "Explain": "此题是记忆题，考查考生对哌唑嗪不良反应的了解。哌唑嗪主要不良反应为部分患者首次服用药物后出现\"首剂现象\"，表现为在用药30～90分钟出现严重的直立性低血压、眩晕、晕厥及心悸等反应，这可能是由于阻断内脏交感神经的收缩血管作用，使静脉舒张，回心血量显著减少所致。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "可乐定"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "哌唑嗪"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "普萘洛尔"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "ACEI"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43023485,
                            "ATestID": 43023485,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "2fccf26437368160c27495e548a280d4605481f3615407510bcf21d67c3adda6b9616f12ee99d091f710fcb75cb69c4a21a77e9a61febd8c5ff40d0a35f2fe17370361a2e6c424f092bc427c0ab3b17acd476ba1e24034709a644faffbf254d577c4fa40ef379021",
                            "Explain": "此题属基本知识试题，考核“硝酸酯类和β受体阻断药合用治疗心绞痛的药理学基础”。常用抗心绞痛药主要通过降低心肌耗氧量，其次增加缺血区心肌供氧来调整氧供需平衡。硝酸甘油对动脉、静脉都有舒张作用，以毛细血管后静脉作用较强，回心血量减少，心容积缩小，降低左心室舒张末期压，室壁肌张力降低，心脏前、后负荷降低，降低心肌耗氧。但因血管扩张、血压下降，可反射性加快心率和心收缩力，增加心肌耗氧，对缺血心肌不利。此外还能舒张心外膜血管和侧支血管，改善心内膜缺血区供血。β受体阻断药，阻断心脏β[XB1.gif]受体，使心收缩力及心率降低，降低心肌耗氧，但对心肌的抑制作用，可增大心容积，延长射血时间而增加心肌耗氧。此外还改善心肌缺血区供血和心肌代谢。β阻断剂普萘洛尔可改善硝酸酯引起的心收缩力增加和心率加快，硝酸甘油可缩小普萘洛尔引起心室容积增大，射血时间延长，两者耗氧降低，具有协同作用。多数考生选择正确答案，表明考生对两类抗心绞痛药的作用及其优缺点掌握较好。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "二者均可使心率减慢"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "在心室压力改变方面二者可相互拮抗"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "二者均可使心室容积减小"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "二者均可使心肌收缩减弱"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "二者均可使心肌耗氧量下降，有协同作用"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028466,
                            "ATestID": 43028466,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "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",
                            "Explain": "本试题是基础和临床相结合的考题。根据患者发病史、症状、体温、血常规和尿培养为大肠埃希菌阳性等，诊断为大肠埃希茵性尿路感染。选择抗生素治疗的备选答案有青霉素、红霉素、灰黄霉素、头孢曲松和林可霉素。根据抗菌谱分析，青霉素主要作用于多数革兰阳性菌、阴性球菌、螺旋体和放线茵。红霉素抗菌谱与青霉素G相似而略广。林可霉素抗菌谱与红霉素相似而略窄，灰黄霉素对浅表真菌感染有效。头孢曲松属第三代头孢菌素类，对革兰阴性杆菌，包括肠杆菌类和铜绿假单胞菌及厌氧菌有较强作用，对阳性菌作用不及第二代。大肠埃希菌属革兰阴性菌。选择正确答案头孢曲松的考生占42.3%，错误选择青霉素和林可霉素分别占29.4%和18.1%。显然，众多考生没有掌握抗生素临床应用的重要基础——抗菌谱。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "青霉素"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "红霉素"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "灰黄霉素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "头孢曲松"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "林可霉素"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43028469,
                            "ATestID": 43028469,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 3,
                    "Style": "B1型题",
                    "Explain": "B1型题：以下提供若干组考题，每组考题共用在考题前列出的A、B、C、D、E五个备选答案。请从中选择一个与问题关系最密切的答案。某个备选答案可能被选择一次、多次或不被选择。",
                    "Score": 1,
                    "Type": "BTEST",
                    "SubType": "单项",
                    "TestCount": 26,
                    "TestItems": [
                        {
                            "Title": "27e70f2df9b54e47e658b7edcb8e6ad54b34a87f068010310baaa2f7d0616d182c01d55167d0972f579c413e7b1a92055b0ef3c7383336b6",
                            "Explain": "",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "Content": "肾小球基底膜和上皮细胞间不规则致密物沉积",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "肾小球基底膜和上皮细胞间有驼峰状致密物沉积",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "肾小球系膜内电子致密物沉积",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "肾小球毛细血管壁增厚呈车轨状或分层状",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "肾小球脏层上皮细胞足突消失，未见电子致密物沉积",
                                    "ItemName": "E"
                                }
                            ],
                            "AllTestID": 43007144,
                            "BTestID": 43001557,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001557,
                                    "Title": "27e70f2df9b54e47e658b7edcb8e6ad54b34a87f068010310baaa2f7d0616d182c01d55167d0972f579c413e7b1a92055b0ef3c7383336b6",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001558,
                                    "Title": "b326510bc8ecbd8b8403a196009d660c3544696d3983cd5865ed3888a70766f3d46a1288bdafec74dc04721db8550fcb6421a23be2550fce235b6c612f699d3e",
                                    "Explain": "常见肾小球疾病的特点比较\n[YS432_590_1.gif]",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "0299c1dd7cdd54db5eb8bacc355a43758106e253c0a5d883f9d4718ccb2c2deb15066aac27f72c90",
                            "Explain": "",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "细动脉壁玻璃样变性"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "细动脉壁纤维素样坏死"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "小动脉内膜纤维化"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "小血管内纤维素样血栓形成"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "纤维结缔组织玻璃样变"
                                }
                            ],
                            "AllTestID": 43007145,
                            "BTestID": 43001559,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001559,
                                    "Title": "0299c1dd7cdd54db5eb8bacc355a43758106e253c0a5d883f9d4718ccb2c2deb15066aac27f72c90",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001560,
                                    "Title": "ecbaeaa052b6141ec7f899b78aea260b7bdbdff2bf41b2133e5ee6c488d2130a9a67ad2499a28e5f",
                                    "Explain": "良性高血压的基本病变是细小动脉壁玻璃样变性，慢性排斥反应的基本病变是小动脉内膜纤维化，引起管腔严重狭窄，从而导致器官缺血。细动脉壁纤维素样坏死为恶性高血压的病理特点。小血管内纤维素样血栓形成为透明血栓的特点。纤维结缔组织玻璃样变见于萎缩的子宫和乳腺间质、瘢痕组织等。",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "d2415887a2c74f4a644808ed8092d2f5",
                            "Explain": "",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "中央型多见"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "周围型多见"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "弥漫型多见"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "常具有内分泌功能"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "肿瘤呈胶冻状"
                                }
                            ],
                            "AllTestID": 43007146,
                            "BTestID": 43001561,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001561,
                                    "Title": "d2415887a2c74f4a644808ed8092d2f5",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001562,
                                    "Title": "047c22b50a3a2c85e11df62cd6a125e8",
                                    "Explain": "肺癌肉眼分型包括中央型、周围型和弥漫型。鳞癌80%～85%为中央型肺癌；腺癌大多数为周围型癌。",
                                    "TestPoint": "",
                                    "Answer": "A",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "43ac24506e974bdb2cc8c8d84395058c4534d9315c4428cefafe204d432f24af",
                            "Explain": "",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "败血症"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "毒血症"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "菌血症"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "脓毒血症"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "病毒血症"
                                }
                            ],
                            "AllTestID": 43007147,
                            "BTestID": 43001563,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001563,
                                    "Title": "43ac24506e974bdb2cc8c8d84395058c4534d9315c4428cefafe204d432f24af",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001564,
                                    "Title": "693c306e8891a224518b9142b273ef3e",
                                    "Explain": "破伤风的病原菌是破伤风杆菌，其侵袭力较弱，仅在入侵部位繁殖，不进入血液，但能产生强烈的外毒素，引起严重的毒血症。流行性脑脊髓膜炎是由脑膜炎双球菌所致，细菌进入血液循环中繁殖并产生毒素，引起败血症。",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "c8d7d20d99f8f374f9ce0a5d826018689779cb8f405693a7ba5ab4858e4643ccf625c6a85aed3bec2eab6abf4ad8ccb8",
                            "Explain": "尿激酶直接激活纤溶酶原，使之成为纤溶酶而溶解纤维蛋白，临床主要用于治疗急性血栓栓塞性疾病，对深静脉栓塞、肺栓塞、眼底血管栓塞均有效，对新鲜血栓效果较好。其他药物只有抑制血栓形成及防止血栓扩大的作用，对己形成的血栓无溶栓作用。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "华法林"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "肝素"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "尿激酶"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "糖皮质激素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "甲苯磺丁脲"
                                }
                            ],
                            "AllTestID": 43007163,
                            "BTestID": 43001565,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001565,
                                    "Title": "c8d7d20d99f8f374f9ce0a5d826018689779cb8f405693a7ba5ab4858e4643ccf625c6a85aed3bec2eab6abf4ad8ccb8",
                                    "Explain": "尿激酶直接激活纤溶酶原，使之成为纤溶酶而溶解纤维蛋白，临床主要用于治疗急性血栓栓塞性疾病，对深静脉栓塞、肺栓塞、眼底血管栓塞均有效，对新鲜血栓效果较好。其他药物只有抑制血栓形成及防止血栓扩大的作用，对己形成的血栓无溶栓作用。",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001566,
                                    "Title": "474e832d631e41ebdc77bdb4b2f4a08dd333f82f3fb1c6150db64e37fc6f3798afbd853850c73ad96f7bec21e337a27306d07c737d8564e014b8a7740613613b",
                                    "Explain": "糖皮质激素不良反应较多，可引起类肾上腺皮质亢进综合征，如满月脸、向心性肥胖、高血压、糖尿等。由于抑制骨基质蛋白质合成，增加钙、磷排泄，抑制肠道钙吸收，可致骨质疏松，严重时易发生骨折和缺血性骨坏死如引起股骨头无菌性坏死。其他不良反应如诱发加重感染、诱发加重溃疡、延缓伤口愈合、影响生长发育等。",
                                    "TestPoint": "",
                                    "Answer": "D",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "e2f77017a0ffa4633bffa01395663aa1e22f6381167be11b3938351307dca32d45de40aec8a34d414a971e486f8fdcc51356d0d7015b5c4a",
                            "Explain": "心脏迷走神经为副交感神经，其节后神经元释放的递质为乙酰胆碱，激动心脏的M型胆碱受体发挥迷走神经兴奋作用。阿托品为M胆碱受体阻断药，可通过阻断心脏的M受体拈抗迷走神经兴奋。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "Content": "酚妥拉明",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "左旋多巴",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "毛果芸香碱",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "阿托品",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "去甲肾上腺素",
                                    "ItemName": "E"
                                }
                            ],
                            "AllTestID": 43007181,
                            "BTestID": 43001567,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001567,
                                    "Title": "e2f77017a0ffa4633bffa01395663aa1e22f6381167be11b3938351307dca32d45de40aec8a34d414a971e486f8fdcc51356d0d7015b5c4a",
                                    "Explain": "心脏迷走神经为副交感神经，其节后神经元释放的递质为乙酰胆碱，激动心脏的M型胆碱受体发挥迷走神经兴奋作用。阿托品为M胆碱受体阻断药，可通过阻断心脏的M受体拈抗迷走神经兴奋。",
                                    "TestPoint": "",
                                    "Answer": "D",
                                    "DealInfo": "经核实，该试题修改为D\n",
                                    "OperateTime": "2017年8月30日"
                                },
                                {
                                    "BTestItemID": 43001568,
                                    "Title": "816ab770c549a0545a047646463b4d41926e77e057a609dfd2786969d116cc501371f85a39adc6be525f9bb598bba4c25e563e61ffed6ac9",
                                    "Explain": "交感缩血管神经为去甲肾上腺素能神经，释放的去甲肾上腺素可激动血管平滑肌α[XB1.gif]受体收缩血管。酚妥拉明为非选择性α受体阻断药，可拮抗交感缩血管神经对血管的收缩作用。",
                                    "TestPoint": "",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001569,
                                    "Title": "51340a0a70a9dfbf889e8165c0c512f2701104d3ecf46c60709f0b18481ad803e2ed44bf5e9d3522",
                                    "Explain": "血管平滑肌存在α[XB1.gif]和β[XB2.gif]受体，前者激动后收缩血管，后者舒张血管。去甲肾上腺素为α受体激动药，通过激动血管平滑肌α[XB1.gif]受体收缩血管。",
                                    "TestPoint": "",
                                    "Answer": "E",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "fa078cec44dc066d8ec925231d77df3120cc694fc4e0dbcb57e223ba2368a62081867ab665fa4af954b7510500acd3da",
                            "Explain": "钙拮抗剂可阻滞Ca[SB2jia.gif]内流，明显张血管，也能增加冠脉流量，尼莫地平有较强的扩张脑血管、增加脑血流的作用，可用于治疗脑血栓形成及脑栓塞、蛛网膜下腔出血的脑血管痉挛。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "尼莫地平"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "利多卡因"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "奎尼丁"
                                }
                            ],
                            "AllTestID": 43007201,
                            "BTestID": 43001570,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001570,
                                    "Title": "fa078cec44dc066d8ec925231d77df3120cc694fc4e0dbcb57e223ba2368a62081867ab665fa4af954b7510500acd3da",
                                    "Explain": "钙拮抗剂可阻滞Ca[SB2jia.gif]内流，明显张血管，也能增加冠脉流量，尼莫地平有较强的扩张脑血管、增加脑血流的作用，可用于治疗脑血栓形成及脑栓塞、蛛网膜下腔出血的脑血管痉挛。",
                                    "TestPoint": "",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001571,
                                    "Title": "0adbdae2123de31eee4abc8cd397abc65ca3dd77fffa1d25f2e4d60745583c846ac9c7fba16d5f31",
                                    "Explain": "心肌缺血时，钠泵、钙泵受抑，但钙的被动转运加强，可使细胞内钙蓄积，造成钙过度负荷，最终导致心肌细胞损害。钙拮抗药如维拉帕米可减少心肌细胞内Ca[SB2jia.gif]量超负荷，故可用于治疗肥厚性心肌病。",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001572,
                                    "Title": "c8d7d20d99f8f374c98d21bb63beb2ed42209b3a188c632d9a405fbaa2c9a986e94f412d4867a729bc7b2d58060556539502b1fb0c3bf392c86be8ff52c31b7e",
                                    "Explain": "利多卡因为Ⅰb类抗心律失常药，抑制Na[SBjia.gif]内流，促进K[SBjia.gif]外流，仅对希-浦系统有作用，主要用于治疗室性心律失常如急性心肌梗死及强心苷引起的室性期前收缩、室性心动过速及心室颤动。",
                                    "TestPoint": "",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001573,
                                    "Title": "82c31000173267b23464363b482ea7b5d8f60a821d40a0852dab41e5ab2947f0fa153e8fd8d59cc11bce68cfece5bc7d830f96d0eeaea368",
                                    "Explain": "维拉帕米是钙拮抗药，对心脏的抑制作用最强，其次为地尔硫[caozhuo.gif]、硝苯地平，可引起负性频率和负性传导作用，使房室传导减慢，不应期延长，折返激动消失，因此为房室结折返引起的阵发性室上性心动过速的首选药。",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "72a0b4c5d55ebb1f6da997f4802348b28d6721b346211eeb4cedd5477650eaa4b1fcfa5c756c69a9",
                            "Explain": "心得安为β受体阻断剂，可导致支气管平滑肌收缩而加重哮喘发作，因此禁用与伴有哮喘患者。严格来说卡托普利因为导致干咳，伴哮喘时也不适宜应用，但相对于β受体阻滞剂，其危害要小的多，所以最佳答案选择B。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "卡托普利"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "心得安"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "尼莫地平"
                                }
                            ],
                            "AllTestID": 43007223,
                            "BTestID": 43001574,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001574,
                                    "Title": "72a0b4c5d55ebb1f6da997f4802348b28d6721b346211eeb4cedd5477650eaa4b1fcfa5c756c69a9",
                                    "Explain": "心得安为β受体阻断剂，可导致支气管平滑肌收缩而加重哮喘发作，因此禁用与伴有哮喘患者。严格来说卡托普利因为导致干咳，伴哮喘时也不适宜应用，但相对于β受体阻滞剂，其危害要小的多，所以最佳答案选择B。",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001575,
                                    "Title": "72a0b4c5d55ebb1f6da997f4802348b2149043347b4ede160294523ad8672685fb57ce4c7dd5634e062f8cac027fa986",
                                    "Explain": "硝苯地平为二氢吡啶类钙拮抗药，扩张血管平滑肌的同时也可扩张其他平滑肌，如支气管平滑肌、胃肠平滑肌等，因此可用于伴有外周血管痉挛及伴有支气管哮喘的患者，能舒张痉挛的血管和支气管平滑肌而改善症状。而尼莫地平主要舒张脑血管，对外周血管的舒张作用没有硝苯地平强，一般较少用于外周血管痉挛。",
                                    "TestPoint": "",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001576,
                                    "Title": "72a0b4c5d55ebb1f46f9dced79e2576c7eaeb01a3c7e427ad3e9a4c8fa03022a2484fbe72f7f826d",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "E",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001577,
                                    "Title": "72a0b4c5d55ebb1f26576764c42ee1242b758a65bd725d8573655fb68369af0df3bec947afc77abc",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "D",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "e5246b51214b171a097a6551f20beebd8af07de294b5902bcd2826f3479cb0b901c8ae536be76f4b",
                            "Explain": "抗疟药分为三类：主要用于控制症状的药物包括氯喹、奎宁、青蒿素等，能杀灭红细胞内期裂殖体，控制症状发作和预防性抑制疟疾症状的发作；主要用于控制远期复发和传播的药物包括伯氨喹，能杀灭肝脏中休眠子，控制疟疾复发，并能杀灭各种疟原虫的配子体，控制疟疾传播；主要用于病因预防的药物包括乙胺嘧啶，能杀灭红细胞外期的子孢子，发挥病因性预防作用。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "奎宁"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "氯喹"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "伯氨喹"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "乙胺嘧啶"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "磷酸咯萘啶"
                                }
                            ],
                            "AllTestID": 43007224,
                            "BTestID": 43001578,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43001578,
                                    "Title": "e5246b51214b171a097a6551f20beebd8af07de294b5902bcd2826f3479cb0b901c8ae536be76f4b",
                                    "Explain": "抗疟药分为三类：主要用于控制症状的药物包括氯喹、奎宁、青蒿素等，能杀灭红细胞内期裂殖体，控制症状发作和预防性抑制疟疾症状的发作；主要用于控制远期复发和传播的药物包括伯氨喹，能杀灭肝脏中休眠子，控制疟疾复发，并能杀灭各种疟原虫的配子体，控制疟疾传播；主要用于病因预防的药物包括乙胺嘧啶，能杀灭红细胞外期的子孢子，发挥病因性预防作用。",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43001579,
                                    "Title": "e5246b51214b171ace27bbc822d0e4b6758cb77f96b1293b0abc0d912f15f3b1899ca1102ba0f7ef",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "18addda8baa1e7d8",
                            "Explain": "记忆题，考查考生对吗啡药理作用和不良反应的了解。吗啡为呼吸中枢抑制药，可用于心源性哮喘的治疗。其过量可引起呼吸功能明显抑制，甚至死亡。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "引起瞳孔扩大"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "引起呼吸抑制"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "引起共济失调"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "引起急性心力衰竭"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "引起周围神经炎"
                                }
                            ],
                            "AllTestID": 43023486,
                            "BTestID": 43003669,
                            "SrcID": 12,
                            "SbjID": 67,
                            "CptID": 528,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43003669,
                                    "Title": "18addda8baa1e7d8",
                                    "Explain": "记忆题，考查考生对吗啡药理作用和不良反应的了解。吗啡为呼吸中枢抑制药，可用于心源性哮喘的治疗。其过量可引起呼吸功能明显抑制，甚至死亡。",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": "",
                                    "OperateTime": "2019年2月11日",
                                    "OldTestJson": "{\"Title\":\"吗啡\",\"Explain\":\"\",\"TestPoint\":\"\",\"Answer\":\"B\",\"Difficulty\":\"\",\"StyleType\":\"BTEST\",\"SubStyleType\":\"ATEST\",\"FrontTitle\":\"\",\"SelectedItems\":[{\"ItemName\":\"A\",\"Content\":\"引起瞳孔扩大\"},{\"ItemName\":\"B\",\"Content\":\"引起呼吸抑制\"},{\"ItemName\":\"C\",\"Content\":\"引起共济失调\"},{\"ItemName\":\"D\",\"Content\":\"引起急性心力衰竭\"},{\"ItemName\":\"E\",\"Content\":\"引起周围神经炎\"}]}"
                                },
                                {
                                    "BTestItemID": 43003670,
                                    "Title": "40b2e5894b8d06466e789c6def213f4f",
                                    "Explain": "解释题，考查考生对碳酸锂不良反应的分析。碳酸锂安全范围较小，其治疗浓度与毒性浓度之间较为接近。碳酸锂较严重毒性反应涉及神经系统，包括精神紊乱、反射亢进、明显震颤、发音困难、惊厥，直至昏迷与死亡。以上反应也是共济失调的表现。",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": "",
                                    "OperateTime": "2019年2月11日",
                                    "OldTestJson": "{\"Title\":\"碳酸锂\",\"Explain\":\"\",\"TestPoint\":\"\",\"Answer\":\"C\",\"Difficulty\":\"\",\"StyleType\":\"BTEST\",\"SubStyleType\":\"ATEST\",\"FrontTitle\":\"\",\"SelectedItems\":[{\"ItemName\":\"A\",\"Content\":\"引起瞳孔扩大\"},{\"ItemName\":\"B\",\"Content\":\"引起呼吸抑制\"},{\"ItemName\":\"C\",\"Content\":\"引起共济失调\"},{\"ItemName\":\"D\",\"Content\":\"引起急性心力衰竭\"},{\"ItemName\":\"E\",\"Content\":\"引起周围神经炎\"}]}"
                                },
                                {
                                    "BTestItemID": 43003671,
                                    "Title": "02ad40aa49c1a2434af256a96360b90e",
                                    "Explain": "第1小题：记忆题，考查考生对吗啡药理作用和不良反应的了解。吗啡为呼吸中枢抑制药，可用于心源性哮喘的治疗。其过量可引起呼吸功能明显抑制，甚至死亡。第2小题：解释题，考查考生对碳酸锂不良反应的分析。碳酸锂安全范围较小，其治疗浓度与毒性浓度之间较为接近。碳酸锂较严重毒性反应涉及神经系统，包括精神紊乱、反射亢进、明显震颤、发音困难、惊厥，直至昏迷与死亡。以上反应也是共济失调的表现。第3小题：记忆题，考查考生对异烟肼不良反应的了解。异烟肼不良反应包括神经系统毒性，主要为周围神经炎和眩晕、失眠，肝损伤和某些过敏症状等。",
                                    "TestPoint": "",
                                    "Answer": "E",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        }
                    ]
                }
            ]
        },
        "isVip": 0,
        "testInfo": [
            {
                "AllTestID": 43023454,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023454,
                        "ChildTableID": -1,
                        "UserCount": 4085,
                        "RightCount": 734,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023454,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43023457,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023457,
                        "ChildTableID": -1,
                        "UserCount": 3630,
                        "RightCount": 3467,
                        "FavCount": 10,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023457,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023458,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023458,
                        "ChildTableID": -1,
                        "UserCount": 3534,
                        "RightCount": 3482,
                        "FavCount": 1,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023458,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43023459,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023459,
                        "ChildTableID": -1,
                        "UserCount": 3746,
                        "RightCount": 634,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023459,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023462,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023462,
                        "ChildTableID": -1,
                        "UserCount": 3290,
                        "RightCount": 3168,
                        "FavCount": 6,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023462,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023464,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023464,
                        "ChildTableID": -1,
                        "UserCount": 3266,
                        "RightCount": 2856,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023464,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023468,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023468,
                        "ChildTableID": -1,
                        "UserCount": 2989,
                        "RightCount": 2801,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023468,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43023469,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023469,
                        "ChildTableID": -1,
                        "UserCount": 3172,
                        "RightCount": 660,
                        "FavCount": 16,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023469,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43023470,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023470,
                        "ChildTableID": -1,
                        "UserCount": 2905,
                        "RightCount": 2562,
                        "FavCount": 16,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023470,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43023471,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023471,
                        "ChildTableID": -1,
                        "UserCount": 2861,
                        "RightCount": 2579,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023471,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43023472,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023472,
                        "ChildTableID": -1,
                        "UserCount": 3035,
                        "RightCount": 569,
                        "FavCount": 20,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023472,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43023473,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023473,
                        "ChildTableID": -1,
                        "UserCount": 2943,
                        "RightCount": 569,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023473,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43023474,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023474,
                        "ChildTableID": -1,
                        "UserCount": 2674,
                        "RightCount": 2465,
                        "FavCount": 10,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 1
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023474,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 1
            },
            {
                "AllTestID": 43023475,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023475,
                        "ChildTableID": -1,
                        "UserCount": 2845,
                        "RightCount": 605,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023475,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023476,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023476,
                        "ChildTableID": -1,
                        "UserCount": 2787,
                        "RightCount": 621,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023476,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43023477,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023477,
                        "ChildTableID": -1,
                        "UserCount": 2745,
                        "RightCount": 589,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023477,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023478,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023478,
                        "ChildTableID": -1,
                        "UserCount": 2689,
                        "RightCount": 659,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 1
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023478,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 1
            },
            {
                "AllTestID": 43023480,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023480,
                        "ChildTableID": -1,
                        "UserCount": 2376,
                        "RightCount": 2216,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 1
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023480,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 1
            },
            {
                "AllTestID": 43028435,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028435,
                        "ChildTableID": -1,
                        "UserCount": 63,
                        "RightCount": 43,
                        "FavCount": 1,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028435,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028436,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028436,
                        "ChildTableID": -1,
                        "UserCount": 64,
                        "RightCount": 31,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028436,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028437,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028437,
                        "ChildTableID": -1,
                        "UserCount": 65,
                        "RightCount": 45,
                        "FavCount": 2,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028437,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028438,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028438,
                        "ChildTableID": -1,
                        "UserCount": 67,
                        "RightCount": 39,
                        "FavCount": 1,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028438,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028440,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028440,
                        "ChildTableID": -1,
                        "UserCount": 72,
                        "RightCount": 52,
                        "FavCount": 3,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028440,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028441,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028441,
                        "ChildTableID": -1,
                        "UserCount": 85,
                        "RightCount": 44,
                        "FavCount": 3,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028441,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028445,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028445,
                        "ChildTableID": -1,
                        "UserCount": 75,
                        "RightCount": 65,
                        "FavCount": 0,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028445,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028446,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028446,
                        "ChildTableID": -1,
                        "UserCount": 70,
                        "RightCount": 62,
                        "FavCount": 0,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028446,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028448,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028448,
                        "ChildTableID": -1,
                        "UserCount": 74,
                        "RightCount": 47,
                        "FavCount": 0,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028448,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028450,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028450,
                        "ChildTableID": -1,
                        "UserCount": 81,
                        "RightCount": 54,
                        "FavCount": 0,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028450,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028451,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028451,
                        "ChildTableID": -1,
                        "UserCount": 74,
                        "RightCount": 55,
                        "FavCount": 1,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028451,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028452,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028452,
                        "ChildTableID": -1,
                        "UserCount": 81,
                        "RightCount": 49,
                        "FavCount": 1,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028452,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028464,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028464,
                        "ChildTableID": -1,
                        "UserCount": 70,
                        "RightCount": 54,
                        "FavCount": 1,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028464,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43007149,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007149,
                        "ChildTableID": -1,
                        "UserCount": 2657,
                        "RightCount": 2240,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 19
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007149,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 19
            },
            {
                "AllTestID": 43007150,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007150,
                        "ChildTableID": -1,
                        "UserCount": 2508,
                        "RightCount": 2410,
                        "FavCount": 10,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007150,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007151,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007151,
                        "ChildTableID": -1,
                        "UserCount": 2609,
                        "RightCount": 2128,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007151,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43007152,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007152,
                        "ChildTableID": -1,
                        "UserCount": 2734,
                        "RightCount": 659,
                        "FavCount": 27,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007152,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43007153,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007153,
                        "ChildTableID": -1,
                        "UserCount": 2429,
                        "RightCount": 2144,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007153,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007154,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007154,
                        "ChildTableID": -1,
                        "UserCount": 2517,
                        "RightCount": 679,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007154,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007155,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007155,
                        "ChildTableID": -1,
                        "UserCount": 2489,
                        "RightCount": 620,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007155,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 43007156,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007156,
                        "ChildTableID": -1,
                        "UserCount": 2407,
                        "RightCount": 687,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007156,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007157,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007157,
                        "ChildTableID": -1,
                        "UserCount": 2345,
                        "RightCount": 703,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007157,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007158,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007158,
                        "ChildTableID": -1,
                        "UserCount": 2371,
                        "RightCount": 488,
                        "FavCount": 32,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 14
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007158,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 14
            },
            {
                "AllTestID": 43007159,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007159,
                        "ChildTableID": -1,
                        "UserCount": 2136,
                        "RightCount": 1922,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007159,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007160,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007160,
                        "ChildTableID": -1,
                        "UserCount": 2191,
                        "RightCount": 713,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007160,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007161,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007161,
                        "ChildTableID": -1,
                        "UserCount": 2037,
                        "RightCount": 1906,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007161,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007162,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007162,
                        "ChildTableID": -1,
                        "UserCount": 2252,
                        "RightCount": 502,
                        "FavCount": 24,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007162,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007164,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007164,
                        "ChildTableID": -1,
                        "UserCount": 2149,
                        "RightCount": 520,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007164,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43007165,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007165,
                        "ChildTableID": -1,
                        "UserCount": 2041,
                        "RightCount": 1575,
                        "FavCount": 23,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 14
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007165,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 14
            },
            {
                "AllTestID": 43007166,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007166,
                        "ChildTableID": -1,
                        "UserCount": 1949,
                        "RightCount": 1745,
                        "FavCount": 9,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007166,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007167,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007167,
                        "ChildTableID": -1,
                        "UserCount": 2170,
                        "RightCount": 411,
                        "FavCount": 23,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007167,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007168,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007168,
                        "ChildTableID": -1,
                        "UserCount": 1903,
                        "RightCount": 1647,
                        "FavCount": 9,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007168,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007169,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007169,
                        "ChildTableID": -1,
                        "UserCount": 1998,
                        "RightCount": 583,
                        "FavCount": 20,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007169,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007170,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007170,
                        "ChildTableID": -1,
                        "UserCount": 1905,
                        "RightCount": 1650,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007170,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 43007171,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007171,
                        "ChildTableID": -1,
                        "UserCount": 1995,
                        "RightCount": 472,
                        "FavCount": 23,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007171,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007172,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007172,
                        "ChildTableID": -1,
                        "UserCount": 1876,
                        "RightCount": 1529,
                        "FavCount": 20,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007172,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007173,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007173,
                        "ChildTableID": -1,
                        "UserCount": 1911,
                        "RightCount": 528,
                        "FavCount": 17,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007173,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 43007174,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007174,
                        "ChildTableID": -1,
                        "UserCount": 1769,
                        "RightCount": 1550,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007174,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007175,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007175,
                        "ChildTableID": -1,
                        "UserCount": 1816,
                        "RightCount": 563,
                        "FavCount": 9,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007175,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007176,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007176,
                        "ChildTableID": -1,
                        "UserCount": 1747,
                        "RightCount": 1464,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007176,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007177,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007177,
                        "ChildTableID": -1,
                        "UserCount": 1686,
                        "RightCount": 1552,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007177,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007178,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007178,
                        "ChildTableID": -1,
                        "UserCount": 1747,
                        "RightCount": 1419,
                        "FavCount": 17,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007178,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007179,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007179,
                        "ChildTableID": -1,
                        "UserCount": 1808,
                        "RightCount": 360,
                        "FavCount": 22,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007179,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007180,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007180,
                        "ChildTableID": -1,
                        "UserCount": 1647,
                        "RightCount": 1509,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007180,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007182,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007182,
                        "ChildTableID": -1,
                        "UserCount": 1679,
                        "RightCount": 1448,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007182,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007183,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007183,
                        "ChildTableID": -1,
                        "UserCount": 1716,
                        "RightCount": 1402,
                        "FavCount": 17,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007183,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007184,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007184,
                        "ChildTableID": -1,
                        "UserCount": 1734,
                        "RightCount": 1353,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007184,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007185,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007185,
                        "ChildTableID": -1,
                        "UserCount": 1706,
                        "RightCount": 1445,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007185,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 43007186,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007186,
                        "ChildTableID": -1,
                        "UserCount": 1655,
                        "RightCount": 1396,
                        "FavCount": 10,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007186,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007187,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007187,
                        "ChildTableID": -1,
                        "UserCount": 1641,
                        "RightCount": 1363,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007187,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007188,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007188,
                        "ChildTableID": -1,
                        "UserCount": 1587,
                        "RightCount": 1468,
                        "FavCount": 10,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007188,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007189,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007189,
                        "ChildTableID": -1,
                        "UserCount": 1695,
                        "RightCount": 434,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007189,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 43007190,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007190,
                        "ChildTableID": -1,
                        "UserCount": 1703,
                        "RightCount": 375,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007190,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007191,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007191,
                        "ChildTableID": -1,
                        "UserCount": 1709,
                        "RightCount": 344,
                        "FavCount": 25,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007191,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            },
            {
                "AllTestID": 43007192,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007192,
                        "ChildTableID": -1,
                        "UserCount": 1629,
                        "RightCount": 471,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007192,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007193,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007193,
                        "ChildTableID": -1,
                        "UserCount": 1620,
                        "RightCount": 423,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007193,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007194,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007194,
                        "ChildTableID": -1,
                        "UserCount": 1580,
                        "RightCount": 386,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007194,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007195,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007195,
                        "ChildTableID": -1,
                        "UserCount": 1520,
                        "RightCount": 1154,
                        "FavCount": 16,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007195,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007196,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007196,
                        "ChildTableID": -1,
                        "UserCount": 1552,
                        "RightCount": 392,
                        "FavCount": 16,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007196,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007197,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007197,
                        "ChildTableID": -1,
                        "UserCount": 1510,
                        "RightCount": 323,
                        "FavCount": 28,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 10
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007197,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 10
            },
            {
                "AllTestID": 43007198,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007198,
                        "ChildTableID": -1,
                        "UserCount": 1371,
                        "RightCount": 497,
                        "FavCount": 17,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007198,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007199,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007199,
                        "ChildTableID": -1,
                        "UserCount": 1337,
                        "RightCount": 1163,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007199,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007200,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007200,
                        "ChildTableID": -1,
                        "UserCount": 1354,
                        "RightCount": 1068,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007200,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007202,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007202,
                        "ChildTableID": -1,
                        "UserCount": 1259,
                        "RightCount": 1030,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007202,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007203,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007203,
                        "ChildTableID": -1,
                        "UserCount": 1244,
                        "RightCount": 919,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007203,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007204,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007204,
                        "ChildTableID": -1,
                        "UserCount": 1165,
                        "RightCount": 1031,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007204,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007205,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007205,
                        "ChildTableID": -1,
                        "UserCount": 1175,
                        "RightCount": 898,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007205,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007207,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007207,
                        "ChildTableID": -1,
                        "UserCount": 1169,
                        "RightCount": 414,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007207,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007208,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007208,
                        "ChildTableID": -1,
                        "UserCount": 1105,
                        "RightCount": 952,
                        "FavCount": 5,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007208,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43007209,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007209,
                        "ChildTableID": -1,
                        "UserCount": 1130,
                        "RightCount": 397,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007209,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007210,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007210,
                        "ChildTableID": -1,
                        "UserCount": 1083,
                        "RightCount": 402,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007210,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007211,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007211,
                        "ChildTableID": -1,
                        "UserCount": 1112,
                        "RightCount": 710,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007211,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007212,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007212,
                        "ChildTableID": -1,
                        "UserCount": 950,
                        "RightCount": 578,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007212,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007213,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007213,
                        "ChildTableID": -1,
                        "UserCount": 977,
                        "RightCount": 737,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007213,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007214,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007214,
                        "ChildTableID": -1,
                        "UserCount": 976,
                        "RightCount": 469,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007214,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007215,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007215,
                        "ChildTableID": -1,
                        "UserCount": 931,
                        "RightCount": 660,
                        "FavCount": 10,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007215,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 43007216,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007216,
                        "ChildTableID": -1,
                        "UserCount": 900,
                        "RightCount": 514,
                        "FavCount": 9,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007216,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007217,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007217,
                        "ChildTableID": -1,
                        "UserCount": 894,
                        "RightCount": 633,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007217,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007218,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007218,
                        "ChildTableID": -1,
                        "UserCount": 912,
                        "RightCount": 603,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007218,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007219,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007219,
                        "ChildTableID": -1,
                        "UserCount": 864,
                        "RightCount": 389,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007219,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007221,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007221,
                        "ChildTableID": -1,
                        "UserCount": 856,
                        "RightCount": 457,
                        "FavCount": 9,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007221,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007222,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007222,
                        "ChildTableID": -1,
                        "UserCount": 887,
                        "RightCount": 590,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007222,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43023482,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023482,
                        "ChildTableID": -1,
                        "UserCount": 912,
                        "RightCount": 523,
                        "FavCount": 9,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023482,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023483,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023483,
                        "ChildTableID": -1,
                        "UserCount": 874,
                        "RightCount": 567,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023483,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023485,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023485,
                        "ChildTableID": -1,
                        "UserCount": 645,
                        "RightCount": 435,
                        "FavCount": 17,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023485,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43028466,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028466,
                        "ChildTableID": -1,
                        "UserCount": 42,
                        "RightCount": 38,
                        "FavCount": 0,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028466,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43028469,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43028469,
                        "ChildTableID": -1,
                        "UserCount": 48,
                        "RightCount": 33,
                        "FavCount": 3,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43028469,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43007144,
                "ChildTableID": 43001557,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007144,
                        "ChildTableID": 43001557,
                        "UserCount": 995,
                        "RightCount": 651,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007144,
                    "ChildTableID": 43001557
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007144,
                "ChildTableID": 43001558,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007144,
                        "ChildTableID": 43001558,
                        "UserCount": 763,
                        "RightCount": 493,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007144,
                    "ChildTableID": 43001558
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            },
            {
                "AllTestID": 43007145,
                "ChildTableID": 43001559,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007145,
                        "ChildTableID": 43001559,
                        "UserCount": 707,
                        "RightCount": 542,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007145,
                    "ChildTableID": 43001559
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007145,
                "ChildTableID": 43001560,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007145,
                        "ChildTableID": 43001560,
                        "UserCount": 964,
                        "RightCount": 511,
                        "FavCount": 16,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 10
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007145,
                    "ChildTableID": 43001560
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 10
            },
            {
                "AllTestID": 43007146,
                "ChildTableID": 43001561,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007146,
                        "ChildTableID": 43001561,
                        "UserCount": 716,
                        "RightCount": 518,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007146,
                    "ChildTableID": 43001561
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007146,
                "ChildTableID": 43001562,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007146,
                        "ChildTableID": 43001562,
                        "UserCount": 643,
                        "RightCount": 573,
                        "FavCount": 5,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007146,
                    "ChildTableID": 43001562
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007147,
                "ChildTableID": 43001563,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007147,
                        "ChildTableID": 43001563,
                        "UserCount": 961,
                        "RightCount": 520,
                        "FavCount": 20,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007147,
                    "ChildTableID": 43001563
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007147,
                "ChildTableID": 43001564,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007147,
                        "ChildTableID": 43001564,
                        "UserCount": 693,
                        "RightCount": 484,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007147,
                    "ChildTableID": 43001564
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007163,
                "ChildTableID": 43001565,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007163,
                        "ChildTableID": 43001565,
                        "UserCount": 690,
                        "RightCount": 460,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007163,
                    "ChildTableID": 43001565
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007163,
                "ChildTableID": 43001566,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007163,
                        "ChildTableID": 43001566,
                        "UserCount": 651,
                        "RightCount": 557,
                        "FavCount": 9,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007163,
                    "ChildTableID": 43001566
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43007181,
                "ChildTableID": 43001567,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007181,
                        "ChildTableID": 43001567,
                        "UserCount": 989,
                        "RightCount": 589,
                        "FavCount": 20,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007181,
                    "ChildTableID": 43001567
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007181,
                "ChildTableID": 43001568,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007181,
                        "ChildTableID": 43001568,
                        "UserCount": 979,
                        "RightCount": 547,
                        "FavCount": 24,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007181,
                    "ChildTableID": 43001568
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007181,
                "ChildTableID": 43001569,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007181,
                        "ChildTableID": 43001569,
                        "UserCount": 745,
                        "RightCount": 504,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007181,
                    "ChildTableID": 43001569
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007201,
                "ChildTableID": 43001570,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007201,
                        "ChildTableID": 43001570,
                        "UserCount": 665,
                        "RightCount": 491,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007201,
                    "ChildTableID": 43001570
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43007201,
                "ChildTableID": 43001571,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007201,
                        "ChildTableID": 43001571,
                        "UserCount": 711,
                        "RightCount": 447,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007201,
                    "ChildTableID": 43001571
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007201,
                "ChildTableID": 43001572,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007201,
                        "ChildTableID": 43001572,
                        "UserCount": 648,
                        "RightCount": 495,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007201,
                    "ChildTableID": 43001572
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007201,
                "ChildTableID": 43001573,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007201,
                        "ChildTableID": 43001573,
                        "UserCount": 705,
                        "RightCount": 452,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007201,
                    "ChildTableID": 43001573
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43007223,
                "ChildTableID": 43001574,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007223,
                        "ChildTableID": 43001574,
                        "UserCount": 693,
                        "RightCount": 443,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007223,
                    "ChildTableID": 43001574
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43007223,
                "ChildTableID": 43001575,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007223,
                        "ChildTableID": 43001575,
                        "UserCount": 709,
                        "RightCount": 376,
                        "FavCount": 17,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007223,
                    "ChildTableID": 43001575
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43007223,
                "ChildTableID": 43001576,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007223,
                        "ChildTableID": 43001576,
                        "UserCount": 639,
                        "RightCount": 521,
                        "FavCount": 5,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007223,
                    "ChildTableID": 43001576
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43007223,
                "ChildTableID": 43001577,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007223,
                        "ChildTableID": 43001577,
                        "UserCount": 924,
                        "RightCount": 409,
                        "FavCount": 14,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007223,
                    "ChildTableID": 43001577
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43007224,
                "ChildTableID": 43001578,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007224,
                        "ChildTableID": 43001578,
                        "UserCount": 660,
                        "RightCount": 510,
                        "FavCount": 16,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007224,
                    "ChildTableID": 43001578
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43007224,
                "ChildTableID": 43001579,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43007224,
                        "ChildTableID": 43001579,
                        "UserCount": 640,
                        "RightCount": 512,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43007224,
                    "ChildTableID": 43001579
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43023486,
                "ChildTableID": 43003669,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023486,
                        "ChildTableID": 43003669,
                        "UserCount": 513,
                        "RightCount": 467,
                        "FavCount": 3,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 0
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023486,
                    "ChildTableID": 43003669
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 0
            },
            {
                "AllTestID": 43023486,
                "ChildTableID": 43003670,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023486,
                        "ChildTableID": 43003670,
                        "UserCount": 732,
                        "RightCount": 573,
                        "FavCount": 10,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023486,
                    "ChildTableID": 43003670
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43023486,
                "ChildTableID": 43003671,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43023486,
                        "ChildTableID": 43003671,
                        "UserCount": 519,
                        "RightCount": 480,
                        "FavCount": 4,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 1
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43023486,
                    "ChildTableID": 43003671
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 1
            }
        ],
        "info": [],
        "encoded": 1,
        "examHistoryID": 0,
        "yimoinfo": [],
        "UserTime": 0
    },
    "status": 200
}